IUMSP	Institut universitaire de médecine sociale et preventive Group for Cardiovascular Disease and Epidemiological Transition (GCT)
	WHO Collaborating Center for Population-Based  Cardiovascular Research and Prevention  in Populations in Health Transition

 

Content of this report

1.		Axes de politiques de recherche
2.		Résumé des résultats obtenus
3.		Publications in peer-reviewed medical journals
4.		Books, leaflets
5.		Publications in non peer-reviewed journals
6.		Presentations in medical conferences with peer review
7.		Other presentations, seminars, teaching
8.		Technical committees, consultations, working groups, official reports
9.		Direction of theses at GCT
10.		Other activities to promote CVD research and prevention in developing countries
11.		Grants and awards
12.		Memberships to professional organizations and boards by main GCT staff
13.		Participation to boards of medical journals
Appendix 1.		CVD research and prevention program in the Seychelles
Appendix 2.		Hypertension in a population in an early stage of epidemiological transition
Appendix 3.		Two-week workshop ‘Starting a CVD prevention program with limited resources’

1. Axes de politiques de recherche

Description de la transition épidémiologique dans les pays en développement, analyse de ses moteurs et modalités de prévention et contrôle des MCV, incluant:

• Relevés épidémiologiques des MCV et de leurs facteurs de risque dans les populations en transition (par exemples styles de vie, tabagisme, hypertension, diabètes, syndrome métabolique, etc.) et l'agrégation (clustering) de ces facteurs.
• Analyse des facteurs associés au niveau individuel ou de la population (par exemples facteurs sociaux, données anthropologiques de naissance, génétique de certains facteurs pertinents, etc.).
• Développement de stratégies de prévention aux niveaux de santé publique et de groupes de personnes à risque. Cela inclus, par exemples, le rôle et l'impact de mesures éducationnelles au niveau individuel (éducation à la santé dans un cadre clinique) ou de masse (plaidoyer, campagnes de sensibilisation) ; des mesures législatives, fiscales et environnementales; et des mesures examinant une utilisation optimale des soins de santé par les personnes à risque ou les patients ('health seeking behaviors') dans des pays dans lesquels l'importance de ces maladies chroniques n'est pas encore reconnue et les ressources sont limitées

2. Résumé des résultats obtenus

Nos recherches ont exploré plusieurs domaines liés à l'émergence des MCV dans les pays en développement, principalement effectuées aux Seychelles et en Tanzanie:

• Distribution des facteurs de risque cardiovasculaire dans la population adulte (Seychelles et Tanzanie), y compris prévalence de maladies sous cliniques -athérosclérose des artères périphériques- (Seychelles).
• Distribution de facteurs de risque chez les enfants (Seychelles).
• Rôle des données anthropologiques de naissance (poids, prise de poids) sur le développement de facteurs de risque ultérieurs (Seychelles).
• Adhérence au traitement pour l'hypertension, facteurs associés, et impact potentiel des stratégies basées sur le dépistage et traitement de l'hypertension aux Seychelles.
• Impact de l'éducation à la santé pour le contrôle de l'hypertension et le tabagisme (Tanzanie).
• Rôle de du gène de la réabsorption du sodium au niveau rénal (ENaC) pour l'hypertension (Seychelles).
• Héritabilité de la fonction rénale dans des famille d'hypertendus (Seychelles).
• Valeur de l'anamnèse familiale pour prédire l'hypertension ou le diabète dans la famille (Seychelles).
• Stratégie optimale pour définir la prévalence de l'hypertension dans une population (Tanzanie).
• Valeur de différents marqueurs électrocardiographiques (ECG) de l'hypertrophie ventriculaire gauche dans une population africaine (Seychelles).
• Impact sur l'arrêt du tabagisme de montrer à des fumeurs leurs propres lésions d'athérosclérose dans leurs artères périphériques (Seychelles).

3. Publications in peer-reviewed medical journals

Note: full text is available on the web site of GCT for most of the recent papers (web site address on cover page)

2003

Lemogoum D, Seedat YK, Mabadeje AFB, Mendis S, Bovet P, Onwubere B, Ngu Blackett K, Lenfant C, M'buyamba Kabangu JR, Belhocine M, Degaute JP, for International Forum for Hypertension in Africa (IFHA). Recommendations for prevention, diagnosis and management of hypertension and cardiovascular risk factors in sub-Saharan Africa. J Hypertens 2003; 21:1993­2000.

Bovet P, Gervasoni JP, Ross AG, Mkamba M, Mtasiwa DM, Lengeler C, Burnier M, Paccaud F. Assessing the prevalence of hypertension in populations: are we doing it right? J Hypertens 2003;21(3):509-517.

Bovet P, Gervasoni JP, Paccaud F. A two-week workshop to promote cardiovascular disease prevention programs in countries with limited resources. Ethnicity and Disease 2003; 13(Suppl 2):S33-S36

Paccaud F. Routine statistics: more interest is needed. J Epidemiol Community Health 2003;57:476-7

Addor V, Wietlisbach V, Narring F, Michaud PA. Cardiovascular risk factor profiles and their social gradient from adolescence to age 74 in a Swiss region. Prev Med 2003 Feb;36(2):217-28

Cornuz J, Pinget C, Gilbert A, Paccaud F. Cost-effectiveness analysis of the first-line therapies for nicotine dependence. Eur J Clin Pharmacol 2003;58(13):201-06.

2002

Bovet P. The cardiovascular disease epidemic: global, regional, local (edito). Trop Med Int Health 2002;7:717-21.

Bovet P, Ross A, Gervasoni JP, Mkamba M, Mtasiwa DM, Lengeler C, Whiting D, Paccaud F. Distribution of blood pressure, body mass index and smoking habits in the urban population of Dar es Salaam, Tanzania, and associations with socio-economic status. Int J Epidemiol 2002;31:240-47.

Bovet P, Burnier M, Madeleine G, Waeber B, Paccaud P. Monitoring one-year compliance to antihypertension medication in the Seychelles. Bull WHO 2002;80:33-39.

Jomini V, Oppliger-Pasquali S, Wietlisbach V, Rodondi N, Jotterand V, Paccaud F, Darioli R, Nicod P, Mooser V. Contribution of major cardiovascular risk factors to familial premature coronary artery disease: the GENECARD project. J Am Coll Cardiol 2002;21; 40(4):676-84.

Paccaud F. Rejuvenating health systems for aging communities. Aging Clin Exp Res 2002;14:314-18.

Stettler N, Bovet P, Shamlaye H, Zemel BS, Stallings VA, Paccaud F. Prevalence and risk factors for overweight and obesity in children from Seychelles, a country in rapid transition: the importance of early growth. Int J Obes 2002;26:214-19.

Doll S, Paccaud F, Bovet P, Burnier M, Wietlisbach V. Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries. Int J Obes 2002;26:48-57.

Bovet P, Perret F, Cornuz J, Quilindo J, Paccaud F. Improved smoking cessation in smokers given ultrasound photographs of their own atherosclerotic plaques. Prev Med 2002;34:215-20.

2001

Bovet P, Paccaud F. Race and responsiveness to drugs in heart failure. New Eng J Med 2001;345:766 (letter).

Paccaud F, Wietlisbach V, Rickenbach M. Body mass index: comparing mean value and prevalence rates from telephone and examination surveys. Rev Epidemiol Sante Pub 2001;49:33-40.

Bovet P, Paccaud F. Alcohol, coronary heart disease and public health: which evidence-based policy? Int J Epidemiol 2001;30:734-737.

Technological Change in Health Care (TECH) Research Network (Fred Paccaud among them). Technological change around the world: Evidence from heart attack care. Health Affairs 2001;20:25-42.

2000

Paccaud F, Schlüter-Fasmeyer V, Wietlisbach V, Bovet P. Dyslipidemia and abdominal obesity: an assessment in three general populations. J Clin Epidemiol 2000;53:393-400.

Jaggy C, Perret F, Bovet P, van Melle G, Zerkiebel N, Madeleine G, Kappenberger L, Paccaud F. Performance of classic electrocardiographic criteria for left ventricular hypertrophy in an African population. Hypertension 2000;36:54-61.

Bovet P, Perdrix J, Larue D, Yersin B, Paccaud F. Poor performance of the CAGE questionnaire in screening for heavy drinking in men in the Seychelles Islands (Indian Ocean). Afr J Drug Alcohol Stud 2000;1:3-20.

Perret F, Bovet P, Shamlaye C, Paccaud F, Kappenberger L. High prevalence of peripheral atherosclerosis in a rapidly developing country. Atherosclerosis 2000;153;9-21.

Zerkiebel N, Perret F, Bovet P, Abel M, Jaggy C, Kappenberger L, Paccaud F. Electrocardiographic findings in a middle-aged African population in the Seychelles islands. J Electrocardiol 2000;33:1-15.

Egger M, Pauw J, Lopatatzidis A, Medrano D, Paccaud F, Davey Smith G. Promotion of condom use in a high-risk setting in Nicaragua: a randomised controlled trial. Lancet 2000;355:2101-5.

Vogel N, Burnand B, Vial Y, Ruiz J, Paccaud F, Hohlfeld P. Screening for gestational diabetes: variation in guidelines. Eur J Obstet Gynecol Reprod Biol 2000;91:29-36.

Yersin V, Bovet P, Mérien F, Clément J, Laille M. VanRanst M, Perolat P. Pulmonary haemorrhage as a predominant cause of death in leptospirosis in Seychelles. Trans R Soc Trop Med Hyg 2000;94:71-6.

1999

Bovet P, Shamlaye H, Paccaud F. Epidemiology and prevention of cardiovascular disease in the Seychelles Islands (Indian Ocean). CVD Prevention 1999;2:261-72.

Fontana P, Mooser V, Bovet P, Shamlaye C, Burnand B, Lenain V, Marcovina S, Riesen W, Darioli R. Dose-dependent inverse relationship between alcohol consumption and serum Lp(a) levels in Black African males. Arterioscler Thromb Vasc Biol 1999;19:1075-82.

Tunstall-Pedoe H, Kuulasmaa K, M?h?nen M, Tolonen H, Ruokokoski E, Amouyel P, for the WHO MONICA Project (Fred Paccaud among investigators). Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 1999;353:1547-57.

McClellan M, Kessler D, for the TECH Investigators (Fred Paccaud among investigators). A global analysis of technological change in health care: The case of heart attacks. Health Affairs1999;18:250-5.

Yersin C, Bovet P, Smits H, Perolat P. Field evaluation of a one-step dipstick assay for the diagnosis of human leptospirosis in the Seychelles. Trop Med Int Health 1999;4:38-45.

Bovet P, Yersin C, Merien F, Davis EC, Perolat P. Factors associated with clinical leptospirosis: a population-based case-control study in the Seychelles islands. Int J Epidemiol 1999;28:583-90.

Perdrix J, Bovet P, Yersin B, Larue D, Burnand B, Paccaud F. Patterns of the alcohol consumption in the Seychelles islands. Alcohol Alcoholism 1999;34;773-85.

Yersin C, Bovet P, Herminie P, Zeller, H. Public health importance of mosquito-borne diseases in the Seychelles (Indian Ocean). Infect Dis Rev 1999;1:189-99.

Bovet P. Yersin C, Herminie P, Lavanchy D, Frei P. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles. Bull WHO 1999;77:923-28.

1998

Bovet P, Larue D, Fayol V, Paccaud F. Blood thiamin status and determinants in the population of Seychelles (Indian Ocean). J Epidemiol Community Health 1998;52:237-42.

Paccaud F, Sidoti Pinto C, Marazzi A, Mili J. Age at death and rectangularisation of the survival curve: trends in Switzerland, 1969-1994. J Epidemiol Community Health 1998;52:412-15.

Aubert L, Bovet P, Gervasoni JP, Rwebogora A, Waeber B, Paccaud F. Knowledge, attitudes and practices on hypertension in a country in epidemiological transition. Hypertension 1998;31:1136-45.

Yersin C, Bovet P, Merien F, Wong T, Panovsky G, Perolat P. Human leptospirosis in Seychelles (Indian Ocean): a population-based study. Am J Trop Med Hyg 1998;59:933-40.

Bourquin MG, Wietlisbach V, Rickenbach M, Perret F, Paccaud F. Time trends in the treatment of acute myocardial infarction in Switzerland from 1986 to 1993: do they reflect the advances in scientific evidence from clinical trials? J Clin Epidemiol. 1998 Sep;51(9):723-32

1997

Yersin C, Bovet P, Wauters JP, Schorderet F, Pescia G, Paccaud F. Frequency and impact of autosomal dominant polycystic kidney disease in the Seychelles (Indian Ocean). Nephrol Dial Transplant 1997;12:2069-74.

Bovet P, Perret F, Shamlaye C, Darioli R, Paccaud F. The Seychelles Heart Study II. Methods and selected basic findings. Seychelles Med Dent J 1997;5:8-24 http://www.seychelles.net/smdj].

Wietlisbach V, Paccaud F, Rickenbach M. Gutzwiller F. Trends in cardiovascular risk factors (1984-1993) in a Swiss Region: results of three population surveys. Prev Med 1997;26:523-33.

1996

Bovet P, Shamlaye C, Paccaud F. Epidemiologic transition to chronic diseases and community-based program of prevention of cardiovascular disease in Seychelles. Cardiology Update (New Delhi) 1996; Jul:10-22.

Madeleine G, Rwebogora A, Bovet P. Working status of sphygmomanometers in health services. Seychelles Med Dent J, 1996;4:2.

1995

Bovet P, for the Investigators of the Seychelles Heart Study. The epidemiologic transition to chronic diseases in developing countries: cardiovascular mortality, morbidity, and risk factors in Seychelles (Indian Ocean). Soz Praventivmed 1995;40:35-43.

Hungerbuhler P, Bovet P, Shamlaye C, Burnand B, Waeber B. Compliance with medication among patients with uncontrolled hypertension in a developing country. WHO Bull 1995;73:437-42.

Sequeira MM, Rickenbach M, Wietlisbach V, Tullen B, Schutz Y. Physical activity assessment using a pedometer and its comparison with a questionnaire in a large population survey. Am J Epidemiol. 1995 Nov 1;142(9):989-99.

1994

Bovet P, Rickenbach M, Wietlisbach V, Riesen W, Shamlaye C, Darioli R, Burnand B. Comparison of serum lipoprotein(a) and its correlates among Black and White populations. Int J Epidemiol 1994;23:20-7.

Bovet P, Hungerbuhler P, Quilindo J, Grettve ML, Waeber B, Burnand B. Systematic difference between blood pressure readings caused by cuff type. Hypertension 1994;24:786-92.

1993

Bovet P, Burnand B, Kappenberger L, Riesen W, Darioli R. Association entre lipoprotéine(a) et maladie coronarienne. Schweiz Med Wochenschr 1993;123:2138-46.

Hungerbuhler P, Bovet P, Shamlaye C. The cardiovascular disease situation in Seychelles (Indian Ocean). Wrld Hlth Statist Q 1993;46;108-12.

Burnand B, Wietlisbach V, Riesen W, Noseda G, Barazzoni F, Rickenbach M, Gutzwiller F. [Blood lipids in the Swiss population: MONICA study 1988-89]. Schweiz Med Wochenschr Suppl. 1993;48:29-37.

Rickenbach M, Wietlisbach V, Beretta-Piccoli C, Moccetti T, Gutzwiller F. [Smoking, blood pressure and body weight in the Swiss population: MONICA study 1988-89]. Schweiz Med Wochenschr Suppl. 1993;48:21-8.

1991

Bovet P, Shamlaye C, Kitua A, Riesen WF, Paccaud F, Darioli R. High prevalence of cardiovascular risk factors in the Seychelles (Indian Ocean). Arterioscler Thromb 1991;11:1730-6.

Pinn G, Bovet P. Alcohol related cardiomyopathy in the Seychelles. Med J Aust 1991;155:529-32.

Tappy L, Bovet P, Jéquier E, Shamlaye C, Darioli R, Burnand B. Relationship of fasting insulin concentration with blood pressure in a representative sample of the adult population of the Seychelles. Int J Obes 1991;15:669-75.

Proceedings of the Symposium on Cardiovascular Diseases, Mahé, Seychelles, 21-23 Mar 1989. Soz Praeventivmed 1991;36(Suppl. 1): S11-89.

Bovet P, Rosalie D, Shamlaye C, Darioli R, Paccaud F. The Seychelles Cardiovascular Disease Study. Soz Praeventivmed 1991;36(Suppl. 1): S3-7.

Gervasoni JP, Bovet P, Shamlaye C, Paccaud F. Guidelines for a collaborative long term program of reduction of cardiovascular risk factors in the population of the Seychelles. Soz Praeventivmed 1991;36(Suppl. 1): S30-3.

Tappy L, Bovet P, Shamlaye C. Prevalence of diabetes mellitus and obesity in the adult population of the Seychelles. Diab Med 1991;8:448-52.

Lavanchy D, Bovet P, Hollanda J, Shamlaye C, Burczak JD, Lee H. High seroprevalence of HTLV-1 in the Seychelles. Lancet 1991;337:248-9.

4. Books, leaflets

Gervasoni JP, Cornuz J. But 11: Adopter des modes de vie plus sains. In: Buts pour la santé en Suisse: La santé pour tous au 21ème siècle (OMS Europe). Ackermann-Liebrich U, Paccaud F, Gutzwiller F, Stutz Steiger T, éditeurs. Berne: Société suisse de santé publique, 2002. (Version également disponible en langue allemande).

Paccaud F, Holly A. Technological Change in Treatment of Myocardial Infarction in Switzerland, 1986-1993. In: McClellan M, Kessler D. Technological Change in Health Care: A Global Analysis of Heart Attacks. Ann Arbor: Michigan University Press, 2002

Bovet P. Alcohol consumption and association with the CAGE questionnaire and physiological variables in the Seychelles Islands (Indian Ocean). In: Surveys of drinking patterns and problems in seven developing countries. Ed: Room R, Demers A, Bourgault C. WHO, Geneva, 2001, p79-101 (WHO/MSD/MSB/01.2).

Jha P, Paccaud F, Nguyen. Strategic priorities for governments and international agencies in tobacco control. In: Jha P, Chaloupka F (Eds). Tobacco control in developing countries. London: Oxford University Press, 2000.

Paccaud F as a member of Working Committee. Research, development, and institutional strengthening for control of cardiovascular disease in developing countries. Ed. Howson C, Reddy S, Ryan TJ, Bale JR. Institute of Medicine (IOM), the Institute of Social and Preventive Medicine and the World Bank. Washington DC: National Academy Press, 1998.

Bovet P, Chong-Seng L, Gervasoni JP, Lionnet G, Quilindo J. Plantes médicinales populaires des Seychelles. Victoria: Space, 1991, 96p (ISBN 2-9506355-0-4).

5. Publications in non peer-reviewed journals

2003

Chiolero A, Bovet P, Burnier M. Recommandations américaines et européennes pour la prise en charge des patients hypertendus: quel impact pour la pratique? Médecine & Hygiène 2003;61:1670-74.

Chiolero A, Bovet P, Burnier M. Amerikanische und Europ?ische Hypertonie-Richtlinien: Welche Auswirkungen haben die transatlantischen Differenzen in der Praxis? CardioVasc 2003;4:17-20.

Bovet P. Section on 'Diet and CVD' in WHO global strategy on diet, physical activity and health: African regional consultation meeting report. WHO 2003 (www.who.int/hpr/NPH/docs/regional_consultation_report_afro.pdf).

Bovet P. The Global Youth Tobacco Survey, Seychelles. Epidemiological Bulletin of Ministry of Health of Seychelles, 2003;1(Sep-Oct):4.

Bovet P. Leptospirosis in Seychelles. Epidemiological Bulletin of Ministry of Health of Seychelles, 2003;1(Sep-Oct):3.

Bovet P. Flash sur l'obésité. Le Fait Médical, 2003;Dec:5-6 (www.lefaitmedical.ch).

Bovet P. Diabetes: what you should know about it. Regar and Nation (newspapers, Seychelles), 13 Nov 2003.

2002

Gervasoni JP, Cornuz J. But 11 de l’OMS: Adopter des modes de vie plus sain. Buts pour la santé en Suisse. Société Suisse de Santé Publique, Berne 2002 ; 35-36.

Cornuz J, Gervasoni JP, Hengstler P, Battegay M, Battegay E. Prévention primaire et dépistage chez l’adulte: quelles sont les perspectives en 2002? Médecine & Hygiène 2002 ; 60 : 2008-16

Bovet P, Viswanathan B, Warren W. The Global Youth Tobacco Survey (GYTS) – Seychelles, 2002. Ministry of Health, Seychelles, 30 Dec 2002 (Report available on the WHO and CDC web sites under ‘GYTS section’).

Bovet P. Tackling cardiovascular disease in the Seychelles: prevention better than cure. Medicus Mundi Suisse Bulletin 2002; 86 (October) (www.medicusmundi.ch/bulletin).

Bovet P, Gustafsson S, Ortegren J, Madeleine G, Viswanathan B. Prevalence of self-reported risk behaviors related to non-communicable diseases among Seychellois students aged 15 years and relationships with personal and other characteristics. Ministry of Health, Victoria, 16 Sep 2002.

Schorr M (refers to paper by Bovet P et al in Prev Med 2002;34:215-220). Viewing own clogged arteries spurs smokers to quit. Reuters Health Information, New York (www.reutershealthinfo.com), 14 Feb 2002.

Bovet P. ‘Health Corner’ (short articles published in 3 main newspapers in Seychelles). What everybody should know on diabetes (30 Aug 2002); What everybody should know on high blood pressure (12 Sep 2002); Control your body weight and please your heart!, 17 Nov 2002.

2001

Bovet P. Assessing diabetes in Seychelles: trends in the incidence of surgical amputations of toe, foot and limb, 1981-2000. Report to the Ministry of Health, 5 Sep 2001.

Bovet P. Tackling cardiovascular disease in the Seychelles: prevention is better than cure. ID21 Insights Health, Mars 2001 (ID21 is enabled by the UK Government Department for International Development (http://www.dfid.gov.uk/) and hosted by the Institute of Development Studies (www.ids.ac.uk/ids).

2000

Wietlisbach V, Rickenbach M, Paccaud F. Traitement de l'hypertension, de la dyslipidémie et de l'obésité en Suisse: faut-il adopter ou adapter les nouvelles recommandations internationales? Médecine & Hygiène 2000;58:586-93.

Bovet P, Gervasoni JP, Paccaud F. Hypertension dans les pays en développement: quelles stratégies de contrôle? Médecine & Hygiène 2000;58:1411-4.

1999 and before

"Labo d’été: chercheurs au bout du monde. Haute tension sous les cocotiers". Article on Seychelels CVD prevention program in L’Hebdo (Ringier, Switzerland), 23 Jul 1998.

Bovet P. Heart disease is more a problem of men than women: true of false? Newsletter of the Seychelles Association of Women Professionals. 1998;3(1):7-8.

Bovet P, Paccaud F. La transition sanitaire dans le monde: quand les pays neufs prennent de l’âge. Journal de Genève, 21 Jun 1996.

6. Presentations in medical conferences with peer review

2003 (oral: O, poster: P)

Bochud M, R.C. Elston RC, Maillard M, Bovet P, Schild L, Burnier M. Heritability of renal function in hypertensive families from an East African country.The American Society of Nephrology 36th Annual Meeting & Scientific Exposition, 12-17 Nov 2003, San Diego, California.

Bovet P, Viswanathan B, Servina M, Warren W. Relation between cigarette smoking, alcohol drinking and marijuana use among secondary school students in the Seychelles islands (Indian Ocean). 12th World Conference on Tobacco or Health, Helsinki, 3-8 Aug 2003. (O)

Viswanathan B, Henderson B, Warren W Bovet P. Comparison of the prevalence of smoking and other behaviors in participants and non-participants to a school-based survey. 12th World Conference on Tobacco or Health, Helsinki, 3-8 Aug 2003. (O)

Bochud M, Flaconnet C, Bovet P, Both N, Paccaud F, Burnier M. Validity of the family history of hpyertension and diabetes among siblings. 13th European Meeting on Hypertension (ESH). Milan 13-17 Jun 2003. Abstract Book S307. (P)

Burnier M, Bochud M, Flaconnet C, Bovet P. White-coat compliance: an important confounding factor in assessing drug efficacy in clinical trials. . 13th European Meeting on Hypertension (ESH). Milan 13-17 Jun 2003. Abstract book S189. (P)

Burnier M, Wietlisbach V, Bovet P, Conen D, Riesen W, Shamlaye C, Paccaud. Associations between acid uric and components of the metabolic syndrome in the population of a country in epidemiologic transition. Journées de la Recherche, University Hospital, Lausanne, 16 Jan 2003. (P)

Bovet P, Gervasoni JP, Mkamba M, Mtasiwa D, Paccaud F, Burnier M How many blood pressure readings should be obtained to assess hypertension in a population ? A population-based study in Dar es Salaam, Tanzania. Journées de la Recherche, University Hospital, Lausanne, 16 Jan 2003. (P)

Bochud M, Falconnet C, Both N, Bovet P, Maillard M, Mooser V, Schild L, Burnier M. Sex difference in the blood pressure response to treatment in East Africa. Research ShowCASE 2003, Case Western Reserve University, Cleveland 4 April 2003, OH, USA.

Gervasoni JP, Bovet P, Rwebogora A, Mkamba M, Paccaud F. Systematic bias between blood pressure readings measured with mercury and automatic sphygmomanometers. Journées de la Recherche, University Hospital, Lausanne, 16 Jan 2003. (P)

Paccaud F, Wietlisbach V, Bovet P. Abdominal obesity and dyslipidemia: an epidemiological analysis in 32 general populations. Journées de la Recherche, University Hospital, Lausanne, 16 Jan 2003. (P)

Bovet P, Stettler N, Madeleine G, Viswanathan B, Paccaud F. Strong relationship between body weight and blood pressure in children. Journées de la Recherche, University Hospital, Lausanne, 16 Jan 2003. (O)

2002

Bovet P, Gervasoni JP, Mkamba M, Mtasiwa D, Paccaud F, Burnier M. How many blood pressure readings should be obtained to assess hypertension in a population? A population-based study in Dar es Salaam, Tanzania. Joint International Society of Hypertension/European Society of Hypertension (ISH/ESH) Meeting, Prague, 23-27 June 2002. (P)

Bovet P, Stettler N, Shamlaye C, Paccaud F: Prevalence of high blood pressure and relationship with obesity and early life characteristics in children of a rapidly developing country. First Annual Nutrition Week, San Diego, CA, 23-27 February 2002, Abstract in Am J Clin Nutri 75(2S):433S. (O)

2001

Stettler N, Bovet P, Shamlaye H, Zemel BS, Stallings VA, Paccaud F. Weight gain during the first year of life and risk for childhood overweight and obesity in the Seychelles, a country in rapid transition. ‘Interdisciplinary Neonatal Nutrition Symposium’ Carlsbad CA, 7-10 Dec 2001 (O).

Mooser V, Wietlisbach V, Jotterand V, Volet M, Lenain V, Paccaud F, Waeber G, Darioli R, Nicod P. Contribution of major cardiovascular risk factors to familial, premature coronary artery disease in Western Switzerland – The GENECARD project. Journée de recherche, Inauguration du Département de recherche, CHUV, Lausanne, 9 Oct 2001 (O).

Paccaud F. on the behalf of the WRIGHT group (World Health Organization Research Into Global Hazards of Travel). Venous thromboembolism and air travel. 49th International Congress of Aviation and Space Medicine, Geneva, 16-20 Sept 2001 (O).

Bovet P, Gervasoni JP, Ross A, Mkamba M, Rwebogora A, Lengeler C. Prevalence of high blood pressure in a population in early stage of epidemiological transition. 5th International Conference on Preventive Cardiology & 4th International Heart Health Conference, Osaka, Japan, 27-31 May 2001. Abstract in Jap J Cardiovasc Dis Prev 2001;36:139 (P).

Bovet P, Shamlaye C, Darioli R, Paccaud F. Incidence and risk factors for fatal myocardial infarction and stroke in Seychelles (Indian Ocean): a population-based cohort study. 5th International Conference on Preventive Cardiology & 4th International Heart Health Conference, Osaka, Japan, 27-31 May 2001. Abstract in Jap J Cardiovasc Dis Prev 2001;36:83 (P).

Bovet P, Stettler N, Shamlaye H, Zemel B, Stallings VA, Paccaud F. Prevalence and risk factors for overweight and obesity in children from Seychelles (Indian Ocean), a country in rapid transition. 5th International Conference on Preventive Cardiology & 4th International Heart Health Conference, Osaka, Japan, 27-31 May 2001. Abstract in Jap J Cardiovasc Dis Prev 2001;36:74 (O).

Paccaud F on the behalf of the WHO protocol group on VTE and AT. Venous thromboembolism and air flight: how to get more evidence?. WHO, Geneva, 17 May 2001 (O).

Gervasoni JP, Bovet P, Ross A, Mkamba M, Rwebogora A, Lengeler C, Paccaud F. Prevalence of high blood pressure in a population in early stage of epidemiological transition. 69ème Assemblée Annuelle de la Société Suisse de Médecine Interne, Lausanne, 10-12 May 2001. Abstract in Swiss Med F 2001;1(Suppl 2):101S (P).

Gervasoni JP, Bovet P, Rwebogora A, Mkamba M, Paccaud F. Systematic bias between blood pressure readings measured with mercury and automatic sphygmomanometers. 69ème Assemblée Annuelle de la Société Suisse de Médecine Interne, Lausanne, 10-12 May 2001. Abstract in Swiss Med F 2001;1(Suppl 2):102S (P).

Bovet P, Burnier M, Gervasoni JP, Waeber B, Paccaud F. One-year compliance to medication in newly diagnosed hypertensive patients screened from the general population of a developing country. 69ème Assemblée Annuelle de la Société Suisse de Médecine Interne, Lausanne, 10-12 May 2001. Abstract in Swiss Med F 2001;1(Suppl 2):101S (P).

Bovet P, Stettler N, Shamlaye H, Zemel B, Stallings VA, Paccaud F. Prevalence and risk factors for overweight and obesity in children from Seychelles (Indian Ocean), a country in rapid transition. 69ème Assemblée Annuelle de la Société Suisse de Médecine Interne, Lausanne, 10-12 May 2001. Abstract in Swiss Med F 2001;1(Suppl 2):101S (P).

Stettler N, Bovet P, Shamlaye H, Zemel BS, Stallings VA, Paccaud F. Risk Factors for overweight and obesity in children from Seychelles (Indian Ocean), a country in rapid transition. Federation of American Societies for Experimental Biology (FASEB) Meeting: Experimental Biology 2001. Orlando, Florida, 31 Mar-4 Apr 2001. Abstract in J Fed Am Soc Exp Biol (FASEB) 2001;15(4):A637 (P).

2000

Paccaud F. Rectangularization of the survival curve: an assessment in Switzerland. Conference on Human Longevity, Individual Life Duration and Growth of the Oldest-Old. Montpellier, France, 23-26 Oct 2000 (O).

1999

Bovet P. Community based prevention of CVD: Seychelles experience (seminar). International Conference on Heart Health in Developing Countries, New Delhi, 10-14 Oct 1999. Cardio Update, Oct-Nov 1999, P24-25 (O).

Bovet P, Nwosu V, Shamlaye H, Udonwa NE, Paccaud F. Prevalence of hypertension and diabetes in a national health center-based register of hypertension and diabetes in Seychelles (Indian Ocean). International Conference on Heart Health in Developing Countries, New Delhi, 10-14 Oct 1999. Cardio Update, Oct-Nov 1999. P 36 (P).

Bovet P, Perret F, Madeleine G, Darioli R, Kappenberger L, Paccaud F. Relationships between conventional cardiovascular risk factors and peripheral atherosclerosis in the general population of a rapidly developing country. International Conference on Heart Health in Developing Countries, New Delhi, 10-14 Oct 1999. Cardio Update, Oct-Nov 1999, P38 (P).

Bovet P, Stettler N, Viswanathan B, Servina C, Gervasoni JP, Paccaud F. Body mass index in children aged 5-16 in Seychelles (Indian Ocean). International Conference on Heart Health in Developing Countries, New Delhi, 10-14 Oct 1999. Cardio Update, Oct-Nov 1999, P46 (P).

Bovet P. Speaker in a Workshop on "Demonstration Projects: Scientific and Organizational Challenges”. International Conference on Heart Health in Developing Countries, New Delhi, 10-14 Oct 1999.

Perret F, Bovet P, Cornuz J, Paccaud F, Quilindo J, Kappenberger L. Higher quit smoking rate in smokers who visualized their own atherosclerotic plaques. Swiss Society of Cardiology, Basel, Switzerland, 25-27 Mar 1999, Médecine Cardiovasculaire 1999;2(Suppl 1), 27S (O).

Perret F, Bovet P, Cornuz J, Quilindo J, Paccaud F, Kappenberger L. Higher quit smoking rate in smokers who were given ultrasound photographs of their own atherosclerotic plaques. 48th Annual Scientific Session of the American College of Cardiology, New Orleans, 7-10 Mar 1999, J Am Coll Cardiol 1999;33(Suppl. A):280A (P).

Perret F., Jaggy C, Bovet P, Abel M, Paccaud F, Kappenberger L. Performance of classical ECG criteria for LVH in black individuals. 48th Annual Scientific Session of the American College of Cardiology, New Orleans, 7-10 March 1999, J Am Coll Cardiol 1999;33 (Suppl. A):236A (P).

1998

Bovet P, Paccaud F, Schlüter-Fasmeyer V, Wietlisbach V. Dyslipidemia and abdominal obesity: an assessment in three general populations. 3rd International Heart Health Conference, Singapore, 30 Aug-2 Sep 98 (O).

Bovet P, Perret F, Quilindo J, Paccaud F. Higher quit smoking rate in smokers who were given ultrasound photographs of their own atherosclerotic plaques. 3rd International Heart Health Conference, Singapore, 30 Aug-2 Sep 98 (P).

Perret F, Bovet P, Shamlaye C, Paccaud F, Kappenberger L. Much higher prevalence of carotid atheroma in a developing African country than in several Western countries. European Society of Cardiology, Vienna, Austria, 22-26 Aug 1998 (P).

Perret F. Higher quit smoking rate in smokers who were given ultrasound photographs of their own atherosclerotic plaques. Symposium on Update in Cardiac Rehabilitation and Exercise Physiology. European Society of Cardiology, Bern, Switzerland, 22-23 May 1998 (O).

Perret F, Bovet P, Shamlaye C, Paccaud F, Kappenberger L. Correlation between left ventricular mass, carotid or femoral wall mass, and blood pressure in a non-selected population. Swiss Society of Cardiology, Interlaken, Switzerland, 14-16 May 1998, Schweiz Med Wochenschr 1998;128(Suppl 97):38S (P).

Perret F, Bovet P, Shamlaye C, Paccaud F, Kappenberger L. Much higher prevalence of carotid atheroma in a developing African country than in several western countries. 47th Annual Scientific Session of the American College of Cardiology, Atlanta, USA, 29 Mar-1 Apr 1998. J Am Coll Cardiol 1999;33 (Suppl.): A 391A (O).

Perret F, Bovet P, Shamlaye C, Paccaud F, Kappenberger L. Correlation between left ventricular mass, carotid or femoral wall mass, and blood pressure in a non-selected population. 47th Annual Scientific Session of the American College of Cardiology, Atlanta, 29 Mar-1 Apr 1998. J Am Coll Cardiol 1999;33 (Suppl. A):523A (P).

1997

Fontana P, Bovet P, Riesen W, Burnand B, Shamlaye C, Mooser V, Darioli R. Alcohol consumption, lipoprotein(a) and hormonal status in middle-aged black African males. 11th International Symposium on Atherosclerosis (International Society of Atherosclerosis), Paris, France, 5-9 Oct 1997 (P).

Perdrix J, Bovet P, Yersin B, Larue D, Burnand B, Paccaud F. Patterns of alcohol consumption in the Seychelles. Research Society on Alcoholism (RSA) Annual Meeting, San Francisco, USA, 19-24 Jul 1997 (P).

Bovet P, Madeleine G, Perret F, Gervasoni JP, Paccaud F, Waeber B. One-year compliance to medication in newly diagnosed hypertensive patients in a developing country. 4th International Conference on Preventive Cardiology, Montréal, Canada, 29 Jun-3 Jul 97. Can J Cardiol 1997;13 (Suppl B):206B (P).

Bovet P, Rwebogora A, Perret F, Darioli R, Riesen W, Paccaud F. Differential relation between lifestyle variables and non-antiatherogenic and antiatherogenic HDL Particles. 4th International Conference on Preventive Cardiology, Montréal, Canada, 29 Jun-3 Jul 1997. Can J Cardiol 1997;13 (Suppl B):96B-97B (P).

Bovet P, Yersin C, Shamlaye C, Gervasoni JP, Wietlisbach V, Paccaud F. Hospital-based incidence of myocardial infarction and stroke in Seychelles. 4th International Conference on Preventive Cardiology, Montréal, Canada, 29 Jun-3 Jul 97. Can J Cardiol 1997;13 (Suppl B):111B (P).

Bovet P, Gervasoni JP, Paccaud F. Lessons from a multi-country evaluation of CVD prevention programs. 4th International Conference on Preventive Cardiology (oral simultaneous session co-sponsored by WHO/World Bank/IUMSP), Montréal, Canada, 29 Jun-3 Jul 97 (O).

Perret F, Bovet P, Shamlaye C, Paccaud F, Kappenberger L. High prevalence of peripheral atherosclerosis in a developing country experiencing fast epidemiologic transition. 4th International Conference on Preventive Cardiology, Montréal, Canada, 29 Jun-3 Jul 97, Can J Cardiol 1997;13 (Suppl B):271B (O).

Aubert L, Bovet P, Gervasoni JP, Rwebogora A, Waeber B, Paccaud F. Knowledge, attitudes and practices towards hypertension in the general population and the hypertensives of a country in epidemiological transition. Journées de Médecine Sociale et Préventive, Bern, Switzerland, 19-20 Jun 1997 (O).

Bovet P, Rwebogora A, Darioli R, Riesen W, Paccaud F. Differential relation between lifestyle variables and antiatherogenic and non-antiatherogenic HDL particles. 65th Annual Meeting of the Swiss Society of Internal Medicine, Geneva, Switzerland, 5-7 Jun 1997. Schweiz Med Wochenschr 1997;127(Suppl 88):25S (P).

Perdrix J, Bovet P, Yersin C, Larue D, Paccaud F. Patterns of alcohol consumption in the Seychelles (Indian Ocean). 41st CIPAT symposium, Cairo, Egypt, 17-22 May 1997 (O).

Perret F, Bovet P, Shamlaye C, Paccaud F, Kappenberger L. Much higher prevalence of atherosclerotic lesions in a developing country than in Western countries. Lausanne, Swiss Society of Cardiology, Lausanne, Switzerland, 17-19 Apr 1997, Schweiz Med Wochenschr 1997;127(Suppl 85):41S (P).

1996

Fontana P. Inverse association between alcohol intake and serum lipoprotein(a). Forum suisse du Groupe suisse des lipides et athérosclérose: biologie cardiovasculaire et implications cliniques. Interlaken, Switzerland, 1-2 Nov 1996 (O).

Paccaud F. Underutilization of medical care as a challenge for priority setting. 1st International Conference on Priorities in Health Care, Stockholm, Sweden, 13-16 Oct 1996 (O).

Yersin C, Bovet P, Madeleine G, Francioli P, Perolat P. Factors associated with human leptospirosis: a population based case-control study in Seychelles. First International Leptospirosis Meeting, Nantes, France, 9-12 Sep 1996 (O).

Yersin C, Bovet P, Wong T, Panovsky G. Clinical presentation of human leptospirosis in Seychelles. First International Leptospirosis Meeting, Nantes, France, 9-12 Sep 1996 (O).

Gervasoni JP, Bovet P, Rwebogora A, Madeleine G, Paccaud F. Evolution rapide des facteurs de risque des maladies cardiovasculaires dans un pays en transition épidémiologique. Les 3èmes Actualités du Pharo & de l’Hôpital Laveran, Marseille, France, 6-7 Sep 1996. Médecine Tropicale 1996:56 (Suppl 3): 57 (O).

Riesen W, Engler H, Bovet P, Darioli R, Abel M. Apolipoprotein E levels and phenotypes in a Black population. Annual Meeting of the American Association for Clinical Chemistry, Chicago, USA, 28 Jul - 1 Aug 1996. Clin Chem 1996;42: S298-9 (P).

Fontana P, Bovet P, Darioli R, Riesen W, Engler H, Burnand B, Rwebogora A. Alcohol dose-dependent reduction of serum Lp(a) in man. 66th Congress of the European Atherosclerosis Society (abstracts-on-disk), Florence, Italy, 13-17 Jul 1996 (P).

Wilson TW, Bovet P, Gervasoni JP, Casar S, Grim CE, Grell GAC, Wilson DM, Grim CM. Hypertension differences among blacks in two middle-income countries: Dominica and the Seychelles. 11th Scientific Meeting of the American Society of Hypertension, New-York, USA, 5-8 May 1996. Am J Hypertension 1996;9 (O).

Fontana P, Darioli R, Riesen W, Engler H, Burnand B, Rwebogora A, Bovet P. Alcohol-dose dependant reduction of Lp(a) levels in man. Annual Meeting of the Swiss Cardiology Society, Zurich, Switzerland, 21-23 Mar 1996. Schweiz Med Wochenschr 1996;126(Suppl. 74/I): 18S (P).

Perret F, Bovet P, Depairon M, Darioli R, Kappenberger L. Mesure de l’épaisseur pariétale artérielle par échographie: faisabilité, reproductibilité et épidémiologie. Annual Meeting of the Swiss Cardiology Society, Zurich, Switzerland, 21-23 Mar 1996. Schweiz Med Wochenschr 1996;126(Suppl. 74/II): 25S (P).

1995

Gervasoni JP, Bovet P, Rwebogora A, Paccaud F. Overall decline in prevalence of smoking in a developing country. 4th Asia Pacific Conference on Tobacco or Health, Chiang Mai, Thailand, 22-24 Nov 1995 (O).

Perret F, Depairon M, Bovet P, Darioli R, Despland P, Abel M, Kappenberger L. Carotid and femoral intima-media thickness (IMT) in the Seychelles Heart Study 1994: reproducibility and mean values according to age and sex. 1st International Symposium: Watching the risk? From arterial wall thickening to clinical symptom. Paris, France, 6-8 Jul 1995 (P).

Riesen W, Engler H, Bovet P, Darioli R, Abel M. Differences in serum concentration and phenotype distribution of Lp(a) between black and white populations. 64th Congress of the European Atherosclerosis Society, Utrecht, Holland, 10-13 Jun 1995 (P).

Bovet P, Darioli R, Madeleine G, Perret F, Gervasoni JP, Burnand B, Paccaud F. Detrimental trends in cardiovascular risk factors levels in the population of a developing country in epidemiological transition (Seychelles). 2nd International Heart Health Conference, Barcelona, Spain, 28 May-1 Jun 1995 (O).

Bovet P, Rwebogora A, Chow L, Perret F, Waeber B, Gervasoni JP, Burnand B. Low predictive value of high blood pressure readings in a population survey to assess hypertension. Assemblée Annuelle de l’Association Suisse contre l’Hypertension, Montreux, Switzerland, 18-20 May 1995. Schweiz Med Wochenschr 1995;125 (Suppl 69):24 (O).

Bovet P, Darioli R, Madeleine G, Burnand B, Riesen W. Association entre la consommation d’alcool et les particules HDL non-athérogéniques. Assemblée Annuelle de la Société Suisse de Médecine Interne, Montreux, Switzerland, 18-20 May 1995. Schweiz Med Wochenschr 1995;125 (Suppl 69):24 (P).

Riesen W, Engler H, Bovet P, Darioli R, Abel M. Unterschiedliche Konzentration und Ph?notypenverteilung von Lp(a) zwischen Schwartzen und Weissen. Assemblée Annuelle de l’Association Suisse de Médecine Interne, Montreux, Switzerland, 18-20 May 1995. Schweiz Med Wochenschr 1995;125 (Suppl 69):43 (P).

1994

Gervasoni JP, Burnand B, Quilindo J, Shamlaye C, Bovet P. Unexpected low prevalence of smoking among adolescents in a developing country. 9th World Conference on Tobacco or Health, Paris, France, 10-14 Oct 1994 (O).

Bovet P, Burnand B, Rosalie D, Darioli R. Effect of sojourning overseas on cardiovascular risk factors in a developing country. 10th International Symposium on Atherosclerosis, Montréal, Canada, 9-14 Oct 1994. Atherosclerosis 1994;109:33 (P).

Bovet P, Burnand B, Shamlaye C, Darioli R. Unusual sex difference in serum HDL-cholesterol: the role of environmental factors. 10th International Symposium on Atherosclerosis, Montréal, Canada, 9-14 Oct 1994. Atherosclerosis 1994;109:22 (P).

Rickenbach M, Wietlisbach V, Bovet P, Gutzwiller F. Trends in modifiable cardiovascular risk factors in the Swiss population between 1985 and 1993: the MONICA study. 12th World Congress of Cardiology and 16th Congress of the European Society of Cardiology, Berlin, Germany, 10-14 Sep 1994 (O).

Bovet P, Burnand B, Rosalie D, Darioli R. Effects of sojourning overseas on cardiovascular risk factors in residents of a developing country. 3rd International Symposium on Multiple Risk Factors in Cardiovascular Disease, Florence, Italy, 6-9 Jul 1994 (P).

Gervasoni JP, Bovet P, Burnand B, Quilindo J, Shamlaye J. Connaissances et comportements relatifs aux maladies cardiovasculaires chez les adolescents dans un pays en voie de dévelopement. Journées Scientifiques de Médecine Sociale et Préventive, Genève, Switzerland, 30 Jun-1 Jul 1994 (P).

Hungerbuhler P, Bovet P, Shamlaye C, Burnand B. Programme de prévention des maladies cardio-vasculaires dans un pays en voie de développement. Journées Scientifiques de Médecine Sociale et Préventive, Genève, Switzerland, 30 Jun-1 Jul 1994 (P).

Bovet P, Hungerbuhler Ph, Gervasoni JP, Shamlaye C, Burnand B, Paccaud F. Epidémiologie de transition: l’exemple des Seychelles. Journées Scientifiques de Médecine Sociale et Préventive, Genève, Switzerland, 30 Jun-1 Jul 1994 (O).

Bovet P, Burnand P, Gervasoni JP, Shamlaye C, Darioli R. Rapport homme/femme inversé de cholestérol-HDL sérique: rôle des habitudes de vie. Unusual sex difference in serum HDL-cholesterol: the role of environmental factors. Annual Conference of the Swiss Society of Internal Medicine, Basel, 9-11 Jun 1994. Schweiz Med Wochenschr 1994;124(Suppl. 59):11 (O).

Bovet P, Hungerbuhler P, Quilindo J, Waeber B, Burnand B. Systematic difference in blood pressure readings due to cuff type. Annual Joint Conference of the Swiss Society of Cardiology and the Swiss Association against Hypertension, Interlaken, Switzerland, 28-30 Apr 1994. Schweiz Med Wochenschr 1994;124(Suppl. 56): 35 (P).

Wietlisbach V, Rickenbach M, Bovet P, Gutzwiller F. Evolution des facteurs de risque cardio-vasculaire dans les populations de Vaud et Fribourg de 1985 à 1993: les résultats de l’étude MONICA. Assemblée Annuelle de la Société Suisse de Cardiologie, Interlaken, 28-30 Apr 1994, Interlaken, Switzerland, Schweiz Med Wochenschr 1994;124(Suppl. 56):35 (P).

Bovet P, Hungerbuhler P, Quilindo J, Waeber B, Burnand B. Systematic difference between blood pressure readings with a standard cuff or a cuff that adapts width to arm circumference. 15th Scientific Meeting of the International Society of Hypertension, Sydney, Australia, 20-24 Mar 1994. J Hum Hypertension, 1994 (P).

1993

Bovet P, Burnand B, Kappenberger L, Darioli R. Serum lipoprotein(a) is an independent correlate of coronary atherosclerosis. 62nd Congress of the European Atherosclerosis Society, Jerusalem, Israel, 5-9 Sep 1993 (P).

Bovet P, Rickenbach M, Wietlisbach V, Riesen W, Shamlaye C, Darioli R, Burnand B. Similar correlates of serum lipoprotein(a) among Black and White populations. 62nd Congress of the European Atherosclerosis Society, Jerusalem, Israel, 5-9 Sep 1993 (P).

Bovet P, Burnand B, Kappenberger L, Darioli R. Serum lipoprotein(a) is an independent correlate of coronary atherosclerosis. Annual Meeting of the Swiss Society for Public Health, Zürich, Switzerland, 24-25 Jun 1993 (P).

Bovet P, Hungerbuhler P, Gervasoni JP, Shamlaye C, Burnand B, Paccaud F. Rising levels of cardiovascular diseases and related risk factors in the Seychelles: new challenges for disease prevention in a developing country. Annual Meeting of the Swiss Society for Public Health, Zürich, Switzerland, 24-25 Jun 1993 (P).

Bovet P, Hungerbuhler P, Quilindo-Edmond J, Waeber B, Burnand B. Systematic difference in blood pressure measurement using a standard cuff or a cuff that adapts bladder width to arm circumference. Annual Meeting of the Swiss Society for Public Health, Zürich, Switzerland, 24-25 Jun 1993 (P).

Bovet P, Rickenbach M, Wietlisbach V, Riesen W, Shamlaye C, Darioli R, Burnand B. Comparison of serum lipoprotein(a) distribution and its correlates in an African and Caucasian populations. Annual Meeting of the Swiss Society for Public Health, Zürich, Switzerland, 24-25 Jun 1993 (P).

Bovet P, Hungerbuhler P, Rosalie D, Burnand B. Changes in serum cholesterol, cigarette-smoking, and diet in individuals of a developing country who have lived abroad: a population-based case-control study. Annual Meeting of the Swiss Society for Public Health. Zürich, Switzerland, 24-25 Jun 1993 (P).

1991

Bovet P, Longnecker MP, Gervasoni J-P, Shamlaye C, Riesen W, Darioli R. Levels of cardiovascular risk factors in the Seychelles (Indian Ocean) are comparable to or higher than in Western countries. 58th European Atherosclerosis Society Meeting, Chicago, USA, 1991 (P).

1990

Bovet P, Shamlaye C, Darioli R, Riesen W, Paccaud F. The cardiovascular risk factor profile in the Seychelles. 56th European Atherosclerosis Society Meeting, Cagliari, Italy, 1990 (P).

Lavanchy D, Bovet P, Hollanda J, Shamlaye C, Frei PC. Prevalence of anti-HTLV-1 serum antibodies in the adult population of the Seychelles Islands. Congrès de la Société Suisse d’Allergie et Immunologie, Lausanne, 1990 (O).

Darioli R, Bovet P, W. Riesen, A. Essinger, L. Kappenberger. La lipoprotéine Lp(a): un nouveau facteur de risque athérogène. 57ème Congrès de la Société Suisse de Médecine Interne, 1990. Schweiz Med Wochenschr 1990;120(Suppl. 32/I):22 (P).

Riesen WF, Bovet P, Darioli R, Rickenbach M, Gutzwiller F. Apolipoproteins, Lp(a) and cholesterol levels in the Swiss and in the Seychellois populations. 55th European Atherosclerosis Society, Brugge, Belgium, 1990 (P).

7. Other presentations, seminars, teaching

2003

Bovet P. Organization of half-day seminar and presentation on "Findings and implications of the Global Youth Tobacco Survey and the Study on Health Behavior in School children Study in Seychelles". Conference on Health Behaviors amongst Students in Seychelles, National Institute of Education, Victoria, Seychelles, 31 Jan 2003.

Paccaud F. Surgical interventions for acute MI: angioplasty, stents, and bypass. Meeting for Disease Control Priorities in Developing Countries - Second Consultation on Cardiovascular Disease, Toronto, 20-22 Mar 2003.

Bovet P. Development of internet-based course virtual course 'Health transition and emerging cardiovascular disease in developing countries: situation and strategies for prevention' for "Virtual Supercourse" of University of Pittsburgh Part I: www.pitt.edu/~super1/lecture/lec12691/index.htm; Part II: (same)12701/index.htm; Part III: (same)12711/index.htm (Nov. 2003). The lectures were awarded "week's best".

Gervasoni JP. L'hypertension artérielle dans les pays en voie de développement, quelles représentations et quels enjeux. Université de Lausanne, Psychologie de la santé 2ème année, 13 Jan 2003.

Gervasoni JP. Non communicable diseases (NCD) with a focus on cardiovascular diseases (CVD) in low and middle-income countries. Core course tropEd, University of Bordeaux, 17-19 Feb 2003.

Gervasoni JP. Non communicable diseases (NCD) with a focus on cardiovascular diseases (CVD) in low and middle-income countries. Diploma course for the Heatlh Care and Management in Tropical Countries, Institut Tropical Suisse. Bâle, 21 Mar 2003.

Bovet P. Prévention du diabète et de ses complications aux Seychelles (and facilitation of a workshop on health education in diabetes). Congrès sur la Nutrition, Diabète et Endocrinologie, St Gilles, La Réunion, 9-12 Apr 2003.

Gervasoni JP. "Two-week course on how to start a prevention and control of CVD". International conference of the Euro-African joint initiative on prevention and control of arterial hypertension and its complications in Africa. Brussel, 10-12 May 2003.

Gervasoni JP, Bovet P. Lutte contre les maladies chroniques, discutants du séminaire sur les politiques régionales de santé: Etude d'un exemple québecois. IUMSP, Lausanne, 16 May 2003.

Gervasoni JP. TropEd: European Network for Education in International Health. Les journées Victor Segalen, les maladies tropicales majeures: une menace pour l'humanité. Bordeaux, 21 May 2003.

Gervasoni JP. Cardiovascular disease in Tanzania. Research to evaluate health systems interventions for vascular risk reduction in primary health care settings of developing countries. ICH meeting, Lausanne, 9 June 2003.

Bovet P. Organization of half-day conference and presentations on 'Cardiovascular disease and women' for 'World Heart Day 2003', attended by ~500 women from various women's associations. International Conference Center, Victoria, 24 Sep 2003.

Bovet P. Hormone replacement therapy and cardiovascular disease: from presumed benefit to potential harm. Weekly Doctors' Meeting, Victoria Hospital, Seychelles, 19 Sep 2003.

Bovet P. Several courses on the epidemiology, prevention and clinical management of ischemic heart diseases, diabetes, and hypertension. School of Health Studies, Victoria, Seychelles (29-30 Aug 2003, 4-5 Sep 2003, 21 Nov 2003, ~10 hrs).

Bovet P. Trends in overweight and behavioral risk factors in children of Seychelles, 1998-2002. Ministry of Health, Victoria, Seychelles, 5 Sep 03.

Bovet P. "Epidemiology of diabetes" & "Management of diabetes based on a patient's total risk". Diabetes Workshop, Victoria, Seychelles, 4-5 Sep 2003.

Madeleine G, Bovet P. Overweight in children of Seychelles: does it matter? Seychelles National Youth Assembly, Victoria, Seychelles, 25 Oct 2003.

Bovet P. The epidemic of overweight: situation and challenges. Continuing education workshop, National Institute of Education, Seychelles, 19 Nov 03 (2 hrs), ~110 teachers from primary and secondary schools.

Bovet P. "Epidemiology and pathophysiology of diabetes", "Total risk approach". One-Day Diabetes Workshop for Health Professionals, Hospital, Praslin, Seychelles, 21 Nov 03.

Gervasoni JP, Mkamba M. Non communicable diseases in developing countries: a challenge for now and the future - Seychelles and Tanzania as examples of Swiss Partnerships. Clinical Research Cooperation with Developing Countries. Workshop "Process of Research Partnership and Impact on Health Development. SAMS, Basel, 10-11 Dec 2003.

2002

Bovet P. Several courses on the epidemiology, prevention and clinical management of ischemic heart diseases, diabetes, and hypertension. School of Health Studies, Victoria, Seychelles (Feb-Oct 2002) (~10 hrs).

Bovet P (leçon inaugurale de Privat Docent at the Faculty of Medicine). L’émergence des maladies cardio-vasculaire dans les pays en développement., University Hospital of Vaud Canton, CHUV, Lausanne ,11 Nov. 2002.

Gervasoni JP. "Assessing the prevalence of hypertension in populations: are we doing it right?” and "Seychelles Program on Prevention and Control of CVD”. Global Forum on Health Research Global Forum on Health Research. Arusha 13-14 Novr 2002.

Gervasoni JP. "Quelle(s) approche(s) de surveillance choisir pour les maladies cardiovasculaires". Cours surveillance OMS. Basel, Swiss Tropical Institute. 3 Sep 2002.

Bovet P. Current issues on health: tobacco. Ministry of Environment and Transport, Victoria, 12 Sep 2002.

Bovet P. Co-organizer and presentations. ‘The epidemiology and physiopathology of diabetes’ and ‘Treatment of diabetes: the total risk approach’. 2-Day Workshop on Diabetes. Ministry of Health, 29-30 Aug 2002.

Bovet P. Panelist. ‘Sports, drugs and smoking’. Youth Voices Forum (Ministry of Youth and Sports). Praslin, Seychelles, 22 Jun 2002.

Bovet P. Co-organizer of 1st National Conference on Tobacco Control and 2 presentations: "The worldwide tobacco epidemic: an overview” and "Economics of tobacco control” (with P. Jha). 1st National Conference on Tobacco Control, Victoria, Seychelles, 27 May 2002.

Bovet P. Organizer, facilitation and several presentations on hypertension epidemiology, diagnosis and management. Two-day Workshop on Hypertension for Health Care Providers. Dar es Salaam, 24-25 Apr 2002.

Paccaud F. Presentation of the WRIGHT project on air travel and venous thromboembolism «Air travel & DVT: Description to be advised». Aircraft interiors EXPO 2002, Hamburg, Germany, 9-11 Apr 2002.

Gervasoni JP, Paccaud F, Pécoud A, Bovet P (organizer, chairmanship, presentations). Meeting for the Community Leaders on the Results of the Dar es Salaam Hypertension Study, 1998-2002. Kurasini, Dar es Salaam, Tanzania, 5 Apr 2002.

Gervasoni JP, Bovet P, Paccaud F, Pécoud A (organizer, chairmanship & several presentations). Workshop on the Results of the Dar es Salaam Hypertension Study, 1998-2002. Joint organization by Temeke Municipal Medical Office of Health and IUMSP, Dar es Salaam, Tanzania, 4-6 Apr 2002.

Gervasoni JP, Bovet P. Non communicable diseases (NCD) with a focus on cardiovascular diseases (CVD) in low and middle income countries. Diploma course for the Heatlh Care and Management in Tropical Countries, Institut Tropical Suisse. Basle,19 Mar 2002.

Bochud M. Progress report of the TANDEM research project on the genetics of hypertension. Central Management Committee, Ministry of Health, Seychelles, 18 Mar 2002

Bochud M. Progress report and some results from the TANDEM research project on the genetics of hypertension. Doctors’ Meeting, Victoria Hospital, Seychelles, 15 Mar 2002.

Bochud M. Santé publique génétique: l'exemple de la génétique de l'hypertension artérielle. IUMSP, Lausanne, 14 Feb 2002.

Bovet P. Surveillance of health indicators and risk factors in 5370 children in 2001. Meeting of School Health Nurses, Victoria, Seychelles. 8 Feb 2002.

Gervasoni JP. "La santé sur le plan international". Cours dans le cadre du diplôme en économie et administration de la santé de l'Université de Lausanne (2 hrs), 4 Feb 2002.

Gervasoni JP. Non communicable diseases (NCD) with a focus on cardiovascular diseases (CVD) in low and middle income countries. Diploma course for tropEd students. Bordeaux 24-25 Jan 2002.

2001

Gervasoni JP. Organizer and presenter. Scientific seminar on the main results of the hypertension study in Dar es Salaam. Kurasini Training and Conference Center, Dar es Salaam, Tanzania, 6 Dec 2001.

Bochud M. ‘Prevention of cardiovascular disease: an update'. One-Day Continuing Medical Education Program. Berjaya Beau Vallon Resort, Seychelles, 1 Dec 2001.

Gervasoni JP. Pourquoi, pour qui, comment faire une campagne de prévention. Ecole d’infirmières, Lausanne, 16 Mar, 1-2 May, 13 Jun, 6-7 Nov 2001 (32 hrs).

Paccaud F (chairman). Introductory remarks and final synthesis. Expert Meeting on Early Determinants of Adulthood CVD and Related Risk Factors: current state of knowledge and future trends. Institute of Social and Preventive Medicine, University of Lausanne, 29-30 Oct 2001.

Bovet P. Prevalence of high blood pressure in children aged 6-16 in the Seychelles islands and effect of birth weight and current weight. Expert Meeting on Early Determinants of Adulthood CVD and Related Risk Factors: current state of knowledge and future trends. IUMSP, University of Lausanne, 29-30 Oct 2001.

Bovet P, Gervasoni JP. Two-Week Workshop on Prevention and Control of Cardiovascular Diseases with Limited Resources, Ministry of Health, Kulhudhuffushi, Maldives, 30 Sep-14 Oct 2001 (including the production of CD-ROM related to the workshop given to all 16 participants).

Bovet P. Emerging epidemic of cardiovascular disease in middle-income countries: the importance of primary prevention. Indira Gandhi Memorial Hospital, Male, Maldives, 27 Sep 2001.

Gervasoni JP. Les principales étapes d’une étude épidémiologique. Ecole d’Infirmières de la Source. Lausanne, 9 May & 14 Nov 2001 (8 hrs).

Gervasoni JP. Quelle(s) approche(s) de surveillance choisir pour les maladies cardiovasculaires. WHO Course on surveillance. Lausanne, Swiss Institute for Experimental Cancer Research, Lausanne, 28 Jun 2001 (3 hrs).

Bovet P. Prevention of CVD in Seychelles: general issues, current program and future challenges. Presentation to Central Management Committee, Ministry of Health, Seychelles. Victoria, Seychelles, 17 Sep 2001.

Bovet P. Presentation of CVD research at the WHO collaborating center of IUMSP. WHO Symposium of the Collaborating Centers in the area of CVD. Osaka, 28 May 2001 (O).

Bovet P. PD course: Epidemiologic transition and burden of cardiovascular disease in developing populations. Faculty of Medicine, University of Lausanne, 1-17 May 2001.

Bovet P. The health transition and implications for heart health in developing countries. Course in series on ‘Community Health within Globalization Context’. DUMSC, Faculty of Medicine, Lausanne, 17 May 2001.

Gervasoni JP. Co-organizer and presentations. ‘Prevention and control of cardiovascular disease: the example of Seychelles’. ‘Epidemiology, risk factors and trends of hypertension in developing countries’, ‘Review of prevention programmes for cardiovascular disease’, ‘Workshop ‘Addressing the emerging pandemic of diabetes and cardiovascular disease in sub Saharan Africa’. Kenya, Nairobi, 16-19 Apr 2001.

Gervasoni JP, Bovet P. Non communicable diseases (NCD) with a focus on cardiovascular diseases (CVD) in low and middle income countries. Diploma course for the Health Care and Management in Tropical Countries, Swiss Tropical Institute, Basel, 3 May 2001.

Bovet P. Screening of cardiovascular risks factors in children. One-day training session for school nurses. Victoria, Seychelles, 22 Feb 2001.

Gervasoni JP. La santé sur le plan international. Course dans le cadre du diplôme en économie et administration de la santé de l'Université de Lausanne, 5 Feb 2001.

2000

Gervasoni JP. Les principales étapes d'une étude épidémiologique. Course for the degree of the Swiss Association of Nursing, Lausanne, 15 Nov 2000 (4 hrs).

Bovet P. Cardiovascular disease issues for women attending family planning services (2 hr). Within 2-week UNDP Course on Family Planning, Victoria, 12 Nov 2000.

Bovet P. Management of cardiovascular disease risk factors based on cardiovascular total risk. Course to PHC doctors, Victoria, Seychelles, 20 Sep 2000 (2 hrs).

Gervasoni JP. Pourquoi, pour qui, comment faire une campagne de prévention. School of Nursing, Lausanne, 7 Mar, 11 Jun 2000 (6 hrs).

Gervasoni JP, Bovet P. Non communicable diseases with a focus on CVD in low and middle income countries. Course on Health Care and Management in Tropical Countries, Swiss Tropical Institute, Basel, 15 May 2000.

Gervasoni JP, Bovet P. Prévention à l'échelle communautaire: l'exemple des Seychelles. Continuing education program, DUMSC, Lausanne, 27 Apr 2000.

Gervasoni JP, Bovet P, Matthies F. Organization an faculty at 2-week workshop on "Starting an efficient cardiovascular disease prevention programs”, Bagamoyo, Tanzania, 9-21 Apr 2000 (supported by University of Lausanne and the Swiss Agency for Development and Cooperation).

Bovet P. Epidemiology of cardiovascular disease. Course to second-year nurses, School of Health Studies, Victoria, 3 & 8 Feb 2000 (4 hrs).

Gervasoni JP. La santé sur le plan international. Course for the diploma in health economy and administration of the University of Lausanne, 31 Jan 2000 (2 hrs).

1999

Bovet P. Patterns of alcohol consumption in Seychelles. Seminar of the Seychelles Medical Association, Ministry of Health, Victoria, 30 Jul 1999.

Gervasoni JP. Pourquoi, pour qui, comment faire une campagne de prévention. Course for the degree of the Swiss Association of Nursing, Lausanne, 18 Mar 1999 (3 hrs) and 11 Jun 1999 (3 hrs).

Gervasoni JP. Evaluation de campagnes de prévention. Course at the Institute for Social Studies, University of Geneva, 4 May 1999 (4 hrs).

Paccaud F. "Chronic diseases”. Course on Health Care and Management in Tropical Countries, Swiss Tropical Institute, Basel, 16 Apr 1999.

Bovet P. Risk factors levels in children: findings in 3000 children in Seychelles. Training Program for School Nurses, Victoria, Seychelles, 25 Mar 1999 (2hrs).

Gervasoni JP. La santé sur le plan international. Course for the diploma in health economy and administration of the University of Lausanne, 25 Jan 1999 (2 hrs).

Bovet P. Several courses to nurse students on epidemiology and clinical management CVD, hypertension, and diabetes. School of Health Studies, Ministry of Health, Victoria, Seychelles, 1999 (5 hrs).

1998

Bovet P. Participation to workshop on Using Burden of Disease and Cost-Effectiveness to Define National Priorities and Essential Packages of Care. Harvard University and World Health Organization, Stowe, USA, 2-15 Dec 1998.

Bovet P. Alcohol patterns and thiamin deficiency in Seychelles. Doctors’ Weekly Meeting, Victoria Hospital, Seychelles, 2 Oct 1998.

Gervasoni JP, Bovet P. Epidemiological transition: a focus on hypertension in developing countries. Chinese-Swiss Epidemiology Meeting Zurich, 27 Sep-4 Oct 1998 (O).

Paccaud F. Programmazione delle attivita sanitarie con Scenari. University of Florence, Italy, 24-26 Sep 1998.

Bovet P. Several courses on the epidemiology, prevention and clinical management of CVD, hypertension, diabetes. Course at the School of Health Studies, Victoria, Seychelles, 10-12 Feb, 4 Mar, 7 & 16 Sep 1998.

Paccaud F. Programmazione delle attivita sanitarie con Scenari. University of Florence, Montecatini, Italy, 16-18 Jun 1998.

Perdrix J. La consommation d’alcool aux Seychelles. Colloques d’alcoologie de la Policlinique Médicale Universitaire, Lausanne, 18 Jun 1998.

Gervasoni JP. Pourquoi, pour qui, comment faire une campagne de prévention. Diploma I course for pregraduate nurses. Lausanne, 15 May 1998 (3 hrs).

Gervasoni JP, Bovet P. Projet de recherche sur les facteurs de risque cardiovasculaire chez les enfants et les adolescents aux Seychelles. Séminaire du Réseau Francophone International de Promotion de la Santé (REFIPS) "La santé du coeur en francophonie”. Lausanne 16 May 1998.

Paccaud F. Capacity building in central and Eastern European countries. Guest Speech held at the Conference on Health Development in Central and Eastern Europe after Transition, co-organized by the Polish Ministry of Health and Social Welfare, the Maria Sklodowska-Curie Cancer Center, the World Bank, the World Health Organization and the Health Promotion Foundation. Warsaw, Poland, 11-13 May 1998 (O).

Bovet P. Should young people care for cardiovascular disease? Youth Festival, General Conference "Embracing the New Millenium”, International Conference Center, Victoria, Seychelles, 23 Apr 1999.

Paccaud F. "Chronic diseases”. Course on Health Care and Management in Tropical Countries, Swiss Tropical Institute, Basel, 6 Apr 1998.

Gervasoni JP. Evaluation de campagnes de prévention. Course at the Institute for Social Studies, University of Geneva, 1 Apr 1998 (4 hrs).

1997

Perret F. Mesures non invasives de l’arteriosclérose: données épidémiologiques des Seychelles. Colloque de l’IUMSP, Lausanne, 17 Dec 1996.

Gervasoni JP, Lengeler C. Research on chronic diseases in developing countries. Seminar über laufende Arbeiten, Swiss Tropical Institute, Basel, 15 Dec 1997.

Paccaud F. Epidemiology of innovation: How new treatments of myocardial infarction spread in Switzerland? Rencontres Européennes de Cardiologie Roussel. Strasbourg, France, 13 Dec 1997 (O).

Bovet P. "Principles of epidemiology” and "Epidemiology of chronic diseases”. Post graduate course for nurses. School of Health Studies, Victoria, Seychelles, 8 & 15 Sep, 10-24 Nov 1997.

Paccaud F. Sistemi servizi sanitari nel mondo occidentale. University of Florence "La gestione del sistema sanitario”, Florence, Italy, 15 Nov 1997.

Bovet P. 12-month compliance to antihypertensive medication: results of a study. Doctors’ Weekly Clinical Meeting, Victoria Hospital, Seychelles, 19 Sep 1997.

Bovet P. Strategies for the prevention of CVD. Senior Executive Meeting, Ministry of Health, Victoria, Seychelles, 21 Aug 1997.

Bovet P. Faculty at the 30th International 10-Day Teaching Seminar of Cardiovascular Epidemiology and Prevention, Phuket, Thailand, 13 Jul-25 Jul 1997.

Bovet P. Primary prevention of cardiovascular disease. Doctors’ Weekly Clinical Meeting, Victoria, Seychelles, 25 May 1997.

Bovet P. Prevention and control of cardiovascular diseases. Seminar for Primary Health Care Doctors, Victoria Hospital, Seychelles, 3 & 17 May 1997.

Gervasoni JP. Pourquoi, pour qui, comment faire une campagne de prévention. Diploma I course for pregraduate nurses. Lausanne, 1 May & 14 May 1997 (6 hrs).

Paccaud F. Medical technology assessment and scenario analysis. University of Modena, Italy, 6-8 Nov 1996.

Bovet P. Faculty and several presentations at the International Society and Federation of Cardiology 29th Ten-Day Teaching Seminar in Cardiovascular Disease Epidemiology and Prevention, Mahé, Seychelles, 30 Jun-12 Jul 1996.

Bovet P. "Lessons from a multi-country evaluation of CVD prevention programs”. Seminar by WHO/World Bank/IUMSP during 4th International Conference on Preventive Cardiology Montréal, Canada, 29 Jun-3 Jul 1997.

Gervasoni JP. Epidémiologie de l'excès de poids. Situation dans les pays développés et en voie de développement. Course for the training of dietitians, Lausanne, 30 May 1996.

Bovet P. Nouvelles des recherches aux Seychelles. Colloque de l’IUMSP, Lausanne, 6 May 1996.

Paccaud F. Journées médico-sociales romandes: atelier sur la prévention, Fribourg, Switzerland, 18-19 Apr 1996.

Paccaud F. Chronic disease. Course for the Degree of Health Care and Management in Tropical Countries, Swiss Tropical Institute, Basel, Switzerland, 4 & 17 Apr 1996 (4 hrs).

Bovet P. Basic concepts, principles and methods in epidemiologic research. Course to health professionals of the Ministry of Health, Seychelles, 26 Jan-19 Apr 1996 (12 hrs).

Wietlisbach V, Rickenbach V. Evolution récente des facteurs de risque cardiovasculaire dans les cantons de Vaud et Fribourg: les résultats de l’étude MONICA. Colloque de l’IUMSP, Lausanne, 9 Jan 1996.

1996

Gervasoni JP, Bovet P. CVD preventive interventions in the Seychelles: design, implementation and evaluation. International Colloquium on Cardiovascular Disease in Middle-Income Countries - which preventive interventions are effective and affordable? Heidelberg, Germany, 18-20 Nov 1996 (O).

Paccaud F. L’intervention dans la communauté: une stratégie prioritaire de prévention. Colloque "Promotion de la santé: projets communautaires en Suisse romande”, organisation RADIX pour les 10 ans de la Charte d’Ottawa, Geneva, 11 Sep 1996 (O).

Paccaud F. Which are the previous Swiss experiences in case ascertainment and cohort studies and can they be integrated in this project? The MONICA experience. FNRS International Workshop, Geneva, 31 May -1 Jun 1996.

1995

Paccaud G. Workshop "Was macht pr?ventive Intervention erfolgreich?” University Institute of Social and Preventive Medicine, Zürich, 17-18 Nov 1995.

Gervasoni J-P. Relevé épidémiologique sur les maladies cardio-vasculaires à Djibouti: une expertise pour l'Organisation mondiale de la santé. IUMSP, Lausanne, 13 Nov 1995.

Bovet P. Individualized reports for participants to a health survey: from data collection to prevention action. IUMSP, Lausanne, 5 Sep 1995.

Bovet P. Faculty at the 28th International 10-Day Teaching Seminar of Cardiovascular Epidemiology and Prevention, International Society and Federation of Cardiology (ISFC), Munich, Germany, 21 Aug-1 Sep 1995.

Paccaud F. Présidence du groupe "Alcool et tabac”. Séminaire de la Fondation suisse pour la promotion de la santé, Hüningen, Switzerland, 17-18 Aug 1995.

Bovet P. Results of the Seychelles Heart Study, Doctors’ Weekly Meeting, Victoria, Seychelles, 7 Jul 1995.

Bovet P. Heart health in Seychelles and implications for school curriculum. Workshop on Heart Health Education for school teachers, Victoria & Baie St Anne Praslin, Seychelles, 19 Apr- 4 May 95.

Bovet P. Rationale for a program of prevention of cardiovascular disease in Seychelles. Meeting of the National Health Committee, Victoria, Seychelles, 19 Apr 1995.

Bovet P, Gervasoni JP, Hungerbuhler P. Six ans de recherche et de prévention des maladies cardio-vasculaires aux Seychelles. Colloque de l’IUMSP, Lausanne, 24 Jan 1995.

1994

Gervasoni JP. Présentation des exposés intéressants de la 9e Conférence mondiale du tabac et de la santé de Paris, Colloque de l’IUMSP, 18 Oct 1994.

1993

Paccaud F. Interview on the debate at the United Nations on economical, social and cultural issues related to health. Radio Suisse Internationale, Geneva, 6 Dec 1993

Paccaud F. Comment promouvoir le droit à la santé? Comité des Nations Unies pour les droits économiques, sociaux et culturels, Journée de travail sur le droit à la santé, Office des Nations Unies, Geneva, 6 Dec 1993.

Bovet P. Lipoprotéine Lp(a), un nouveau facteur de risque de maladie coronarienne. Forum Romand de Cardiologie, Yverdon, 28 Oct 1993 (O).

Bovet P. Enquête épidémiologique des facteurs de risque cardio-vasculaire ischémique aux Seychelles: quels enjeux ? IVème Rencontre Annuelle du Groupe Suisse Lipides, Glion sur Montreux, 21-22 Oct 1993 (O).

Paccaud F. Conférence principale pour le Jubilé des vingt ans de Medicus Mundi Suisse: "Enjeux pratiques et éthiques en santé publique - Similitudes et différences au Sud et au Nord", Musée international de la Croix-Rouge, Geneva, 8 May 1993.

Gervasoni JP. Health knowledge and behaviors among adolescents in the Seychelles. MSc thesis, London School of Hygiene and Tropical Medicine, University of London, 1993.

1992

Bovet P. Maladies cardiovasculaires dans un pays en transition épidémiologique: la situation aux Seychelles. Groupe de Travail Santé et Développement, Institut Universitaire d’Etudes du Développemen, Geneva, 1 Dec 1992.

Bovet P. Les maladies cardio-vasculaires: quelle prévention? Conférence-débat. Semaines Onusiennes de Promotion de la Santé. Geneva, 13-22 Oct 1992.

Bovet P. The Seychelles Cardiovascular Diseases Study 1989. Symposium on Strategies for Prevention of Cardiovascular Diseases, Mahé, Seychelles, 11-13 Aug 1992 (O).

Gervasoni JP. La Digue diabetes and cardiovascular diseases survey 1991. Symposium on Strategies for Prevention of Cardiovascular Diseases, Mahé, Seychelles, 11-13 Aug 1992 (O).

Paccaud F. Follow-up of an intervention program: the MONICA project as an example. Symposium on Strategies for Prevention of Cardiovascular Diseases, Mahé, Seychelles, 11-13 Aug 1992 (O).

Gervasoni JP. Seychelles and high blood pressure as priority. Symposium on Strategies for Prevention of Cardiovascular Diseases, Mahé, Seychelles, 11-13 Aug 1992 (O).

1990

Bovet P. The cardiovascular risk factor profile in the Seychelles. Proc. Symposium on Cardiovascular Diseases, Mahé, Seychelles, 21-23 Mar 1990. Soz Praeventivmed 1991;36(Suppl. 1):S13 (O).

Bovet P. Drinking habits and related clinical findings in the Seychelles. Symposium on Cardiovascular Diseases, Mahé, Seychelles, 21-23 Mar 1990. Soz Praeventivmed 1991;36(Suppl. 1):S16 (O).

Bovet P. Prevalence of diabetes mellitus in the Seychelles. Symposium on Cardiovascular Diseases, Mahé, Seychelles, 21-23 Mar 1990. Soz Praeventivmed 1991;36(Suppl. 1):S25 (O).

Bovet P. The cardiovascular benefits of physical activity. World Health Day on the theme ‘Promoting physical activities for senior citizens’, Roche Caiman Sports Complex, Victoria, Seychelles, 7 Apr 1999.

8. Technical committees, consultations, working groups, official reports

(Committees of long term appear under 12)
2003

Bovet P. Task Force for the development of a CVD workshop in Africa. Centers for Disease Control and Prevention, Accra, Ghana, 7-11 Dec 2003. (Presentation published in Ethn Dis 2003; 13 Suppl 2:S33-S36).

Bovet P (technical adviser). Presentation on 'Nutrition and cardiovascular disease'. Regional Consultation on WHO Global Strategy on diet, physical activity and health. WHO, Harare, Zimbabwe, 18-20 Mar 2003.

Bovet P. Presentations. International Forum for Hypertension in Africa (IFHA). Université Libre de Bruxelles, 10-12 May 2003.

Bovet P. (scientist associated to network). Global Adherence Interdisciplinary Network, WHO, Geneva, 2003. (http://www.who.int/chronic_conditions/adherencereport/en/print.html).

Bovet P (representative of Seychelles government). 6th Intergovernmental Negotiating Body (INB6) on the Framework Convention of Tobacco Control (FCTC), Geneva; 17-28 Feb 2003.

Bovet P (representative of Seychelles government, rapporteur of meeting). 5th WHO AFRO Regional Meeting on the Framework Convention on Tobacco Control (FCTC), Dakar, 6-10 Feb 2003.

Bovet P (rapporteur & country presentation). Workshop on Research to evaluate health system interventions for vascular risk reduction in PHC setting of developing countries, Initiative for Cardiovascular Health Research in the Developing Countries (ICHealth). Lausanne, 9-10 Jun 2003.

Gervasoni JP. President of tropEd in 2003 and member of the Executive Committee. tropEd General Assembly, Amsterdam 23-25 Jan 2003, Copenhagen 22-24 May, Heidelberg 11-13 Sep 2003.

2002

Bovet P (representative of Seychelles government & spokesperson for WHO AFRO Group). 5th Intergovernmental Negotiating Body (INB5) on the Framework Convention of Tobacco Control (FCTC), Geneva 14-25 Oct 2002.

Bovet P (representative of Seychelles government, member of writing committee). 4th WHO AFRO Regional Meeting on the Framework Convention on Tobacco Control (FCTC), Lilongwe, Malawi, 2-6 Sep 2002.

Bovet P (representative of the Seychelles government and report on "report of situation on illicit tobacco trade in Seychelles”. International Conference on Illicit Tobacco Trade, New York, United Nations (meeting sponsored by the U.S: Bureau of Alcohol, Tobacco and Firearms and WHO). 30 Jul - 1 Aug 2002.

Bovet P. (country presentation and rapporteur of a working group). Consultative WHO Meeting on Global Policy for Smoking Cessation. Moscow, 14-15 Jun 2002.

Paccaud F. Invited to the Meeting « Poverty and Health: Evidence and Action in WHO’s European Region ». 1st Follow-up to the WHO Regional Committee Resolution on Poverty and Health. Düsseldorf, Germany, 18-19 Apr 2002.

Paccaud F. Presentation of the WRIGHT Project on Air Travel and Venous Thromboembolism « Air travel & DVT: Description to be advised ». Aircraft interiors EXPO 2002, Hamburg, Germany, 9-11 Apr 2002.

Paccaud F. Introduction of the Meeting « Initiative for Cardiovascular Health Research in Developing Countries » (organization Srinath Reddy), Lausanne, 25 Mar 2002.

Pacaud F (convener, introduction), Bovet P (discussant). Consultation for the review of the 2nd edition of the book ‘Disease Control Priorities in Developing Countries (DCPP) - Cardiovascular Diseases’. "What do we know and what do we need to know for control of CVD in developing countries”? (WHO, NIH, World Bank, and others). Lausanne, 24 Mar 2002.

Bovet P (representative of Seychelles government & spokesperson for WHO AFRO Group). 4th Intergovernmental Negotiating Body (INB4) on the Framework Convention of Tobacco Control (FCTC), Geneva 18-23 Mar 2002.

Bovet P (representative of the Seychelles government, member of the writing committee). 3rd WHO AFRO Regional Consultative Meeting on the Framework Convention of Tobacco Control (FCTC), Abidjan, 26 Feb-1 Mar 2002.

Paccaud F. TropEdEurop (Board of governors).

Gervasoni JP. TropEdEurop Steering Committee. Bordeaux 25-28 January 2002, Lisbon 6-8 September2002.

Paccaud F. Steering Group of the Initiative for Prevention of cardiovascular diseases in developing countries (WHO WB joint initiative), Washington.

Paccaud F. Steering Group of Global Forum for Health, Geneva.

Paccaud F. Elected member of the Scientific Council on Epidemiology and Prevention of the World Heart Federation.

Paccaud F. Cooperation with the Working Group 5, Commission on Macroeconomics and Health (WHO-World Bank initiative).

Paccaud F. Chairman of The WRIGHT group (for: WHO Research Into Global Hazards of Travel), Project on Air travel and Venous Thromboembolism, Amsterdam, Geneva, Leicester, Leiden, London, Lausanne, Newcastle.

Bovet P. Consultant and Director of the Unit for Prevention and Control of CVD, Ministry of Health, Seychelles.

Bovet P (chair). National Committee for Tobacco Control. Seychelles.

Bovet P. Member of the International Advisory Board of the South Asian Association for Regional Cooperation (in association with the SAARC Cardiac Societies of India, Pakistan, Bangladesh, Nepal, Sri Lanka).

Bovet P, Gervasoni JP. Comité du Département Interdisciplinaire d'Etudes Cœur et Vaissaux (DIECV) - Certificat d'Etudes Complémentaires en Recherche Cardiovasculaire (CECRC).

Bovet P. Member of Task Force for Integrated Disease Surveillance and Response (IDSR), Ile Anonyme, Seychelles, 19 Feb 2002.

2001

Paccaud F. Invited participant to Pre-Advisory Board Meeting WHO Research Studies on Air Travel and Venous Thromboembolism. WHO, Geneva, 13-14 Dec 2001.

Bovet P (representative of Seychelles government, spokesperson for WHO AFRO Group). 3rd Intergovernmental Negotiating Body (INB3). Geneva 22-28 Nov 2001.

Bovet P. Burden of Disease Attributable to Alcohol and Illicit Drugs – Data from Seychelles. Report requested by Management of Substance Dependence, WHO, Geneva (report sent on 10 Nov 2001).

Bovet P. Regional Survey of Country Specific Data - Seychelles 2001. Report requested by WHO Regional Surveillance Systems for Tobacco Control, TFI, WHO, Harare (report sent on 11 Sep 2001).

Paccaud F. Participation to Global Forum for Health Research. WHO, Geneva, 9-12 Oct 2001.

Bovet P, Gervasoni JP. Partnership council meeting of Global Forum on Health Research. WHO, Geneva, 16 Aug 2001.

Paccaud F. Working Group 5: Technical Meeting of Lead Authors and Steering Committee of the Commission on Macroeconomics and Health. A WHO commission examining the interrelations among investment in health, economic growth, and poverty reduction. London, 11-12 Jul 2001.

Bovet P, Gervasoni JP. Meeting of Interested Parties. Noncommunicable Diseases and Mental Health. World Health Organization, Geneva, 28-29 Jun 2001.

Bovet P. Meeting of the Council on Epidemiology and Prevention of the World Heart Federation of Prevention, 26 & 29 May 2001, Osaka, Japan.

Gervasoni JP. Steering committee meeting de TropEd, Alicante, Spain, 26-30 Jan 2001 & Budapest, Hungary, 17-21 May 2001.

Bovet P (representative of Seychelles government and spokesperson for he African Group). 2nd Intergovernmental Negotiating Body on the Framework Convention on Tobacco Control, Geneva, 30 Apr-5 May 2001.

Bovet P (chair of the meeting). WHO Consultative Meeting on Prevention and Control of Noncommunicable Diseases in the African Region, Harare, Zimbabwe, 2-4 Apr 2001.

Paccaud F. Working Group 5: Technical Meeting of Lead Authors and Steering Committee of the Commission on Macroeconomics and Health (WHO commission examining the interrelations among investment in health, economic growth, and poverty reduction, Merson M and Paccaud F as chairmen). Lausanne, 25-29 Mar 2001.

Paccaud F. WHO Consultation on air Travel and Venous Thromboembolism, Geneva, 12-13 Mar 2001.

Bovet P (delegate of the Republic of Seychelles). Consultative Meeting of the African Region on the Framework Convention on Tobacco Control; Johannesburg, South Africa, 12-14 Mar 2001.

Paccaud F. Development of a comprehensive protocol under the auspices of World Health Organization (Division of chronic diseases) by Mendis S (Geneva), Kesteven P (Newcastle), Bueller P (Amsterdam), Scurr J (London), Toff W (Leicester), Rosendaal FR (Leiden) and Paccaud F (Lausanne) on Air Travel and Venous Thromboembolism. WHO, Copenhagen, Denmark, 22-25 Feb 2001.

Bovet P. Chairman of Seychelles National Committee for Tobacco Control (appointed by Minister of Health).

2000

Paccaud F. Organization and chairman of the Meeting of the Working Group 5 (Technical Meeting of Lead Authors and Steering Committee) "Improving Health Outcomes of the Poors”. A WHO commission examining the interrelations among investment in health, economic growth, and poverty reduction, Bagamoyo, Tanzania, 30 Oct-4 Nov 2000.

Bovet P. Presentation of a report "Policy for tobacco situation in Seychelles” and rapporteur of a Working Group at the Intercountry Meeting on Tobacco Control Policy and Programming in the African Region, Nairobi, Kenya, 23-28 Oct 2000.

Paccaud F. Working Group on Health Promotion and Disease Prevention in the ECHTA/ECAHI project, for discussion about work plan and selection of candidate interventions, Stockholm, 21 Oct 2000.

Bovet P. Representative of the Republic of Seychelles in the 1st Intergovernmental Negotiating Body (INB1) on the WHO Framework Convention on Tobacco Control. Geneva 16-21 Oct 2000.

Paccaud F. Participation aux Forums d’experts organisés par la Commission d’étude sur les services de santé et les services sociaux créés par le Gouvernement du Québec, Montréal, Canada, 1-5 Oct 2000.

Bovet P. Report on "Tobacco Global Situation in the Republic of Seychelles” for the General Secretariat of the Organization of African Unity (OAU), 26 Sep 2000.

Bovet P. "Questionnaire on Regional Tobacco Surveillance Systems: Regional Survey of Country Specific Data 2000” for the WHO AFRO Regional Office, Harare, 20 Aug 2000.

Bovet P. Preparation of procedures for surveillance of MI, stroke, diabetes, hypertension and cancer. Task Force for National Integrated Disease Surveillance. Ministry of Health, Seychelles, Jun-Sep 2000.

Bovet P. Representative of Seychelles Government at the 2nd Working Group for a Framework Convention on Tobacco Control, WHO, Geneva, 27-31 Mar 2000.

Bovet P. Preparation and presentation of guidelines for the management of hypertension for primary health care in Seychelles. Ministry of Health, Victoria, Seychelles, 21 Feb 2000.

Bovet P. Rapporteur of a working group in the Conference "Promoting Excellence in Health”, Victoria, Seychelles, 28-29 Jan 2000.

1999

Bovet P. Representative for Seychelles at the 1st Working Group for a Framework Convention on Tobacco Control, WHO, Geneva, 25-29 Oct 1999.

Bovet P. Temporary adviser and presentation of a report in the WHO Consultation on Future Strategies for the Prevention and Control of Non-communicable Diseases, WHO/HQ, Geneva, 27-30 Sep 1999.

Bovet P. Report on the available evidence of the Effects/Impact of Alcohol on Health in Seychelles, for the Seychelles Drug and Alcohol Council, Sep 1999.

Bovet P. Member of the Epidemiology and Disease Surveillance Working Group. Preparation of a Plan of Action 2000-2004 for Integrated Disease Surveillance and Epidemic Preparedness and Response. Ministry of Health, Seychelles, 12-16 Jul 1999.

Paccaud F. Guest speech: Accessing existing information. Consultation on CVD Research in Developing Countries: a WHO-MRC consultation on the behalf of the Forum for global health". Cape Town, South Africa, 11-13 Feb 1999.

1998

Bovet P. Presentation of a report and participation to WHO Consultation on Alcohol Epidemiology in Developing Societies. Mexico, 13-15 Aug 1998.

Paccaud F. Meeting on the future of collaboration between IUMSP, World Bank and International Society and Federation of Cardiology. Washington, 13 Mar 1998.

Paccaud F. Expert for an International Conference on Technological Change and Medical Expenditure Growth, Stanford University, 26-28 Feb 1998.

Paccaud F. First Consultation on the World Bank Document on the Policy of Tobacco Control in Developing Countries. World Bank, IUMSP, Cape Town, South Africa, 21 Feb 1998.

Paccaud F. Conference on "Economics of tobacco control: Towards an optimal policy mix”. Organization: School of Economics of Cape Town, IUMSP-Lausanne, Rockefeller Foundation, The Swedish International Development Cooperation Agency, The World Bank. Cape Town, South Africa, 18-20 Feb 1998.

1997

Paccaud F. Expert at the 9th Council of the MONICA principal investigators, Milan, Italy, 1 Oct 1997.

Bovet P, Gervasoni JP. Consultation for the World Bank: "An assessment of the Comprehensive Countrywide Cardiovascular Diseases Control Program in Hungary”. Budapest, 14-18 Apr 1997.

1996

Paccaud F. Consultation for the WHO Regional Office for the prevention of CVD in countries in epidemiological transition, Muscat, Oman, 9-10 Jul 1996.

Gervasoni JP. Working Group on Health Promotion Scenario Development, WHO, Geneva, 29-30 May 1996.

1995

Paccaud F. Assignment Report on Cardiovascular Diseases in Djibouti. WHO Regional Office of the Eastern Mediterranean, Alexandria, 16-23 Dec 1995.

Somaini B. Evaluation of the Program for the Control and Prevention of Cardiovascular Diseases in the Seychelles, 20-27 Nov 1995.

Paccaud F, Gervasoni JP. Consultation report for the preparation of an epidemiological survey of cardiovascular diseases and their risk factors in the Republic of Djibouti. WHO Regional Office of the Eastern Mediterranean, Alexandria, 3-11 Jan 1995.

9. Direction of theses at GCT

Doll S.Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries. (Doll S, Paccaud F, Bovet P, Burnier M, Wietlisbach V). Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries. Int J Obesity 2002;26:48-57.

Pigois E. Report of the Survey on Tobacco Use and Attitudes towards a Smoke-Free Policy in International Labor Organization in Geneva. Director: Paccaud F, Supervision: Gervasoni JP. (Thesis accepted by the Faculty of Medicine of the University of Lausanne on 4 Sep 2001.

Jaggy C. Electrocardiographic diagnosis of left ventricular hypertrophy in blacks. Hypertension 2000;36;54-61. (Thesis accepted by the Faculty of Medicine of the University of Lausanne on 24 Oct 2000; Prix de la Faculté de Médecine, Université de Lausanne).

Zerkiebel N. Epidemiology of basic ECG measurements according to age and sex in a non-selected predominantly black population. Journal of Electrocardiology 2000;33:1-15. (Thesis accepted by the Faculty of Medicine of the University of Lausanne on 5 Sep 2000; Prix de la Fondation de Médecine Sociale et Préventive).

Schlüter-Fasmeyer V. Dyslipidemia and abdominal obesity: an assessment in three general populations. Journal of Clinical Epidemiology 2000;53:393-400.

Perdrix J. Patterns of alcohol consumption in the Seychelles (Indian Ocean). Alcohol & Alcoholism 1999;34;773-785.

Fontana P, Mooser V, Bovet P, Shamlaye C, Burnand B, Lenain V, Marcovina S, Riesen W, Darioli R. Dose-dependent inverse relationship between alcohol consumption and serum Lp(a) levels in Black African males. Arteriosclerosis Thrombosis & Vascular Biology 1999;19:1075-1082.

Aubert L. Knowledge, attitudes and practices toward hypertension in the hypertensives and the general population of a country in epidemiologic transition. Hypertension 1998;31:1136-1145.

Paccaud F, Sidoti Pinto C, Marazzi A, Mili J. Age at death and rectangularisation of the survival curve: trends in Switzerland, 1969-1994. Journal of Epidemiology and Community Health 1998;52:412-415.

10. Other activities to promote CVD research and prevention in developing countries

1994-2003

Bovet P. Epidemiologist consultant and head, Unit for Prevention and Control of Cardiovascular Disease, Ministry of Health of Seychelles.

Bovet P. Participation in ~10-20 radio and TV programs every year on CVD prevention and control, Seychelles, 1994-2001.

Bovet P. Co-organization of national events in Seychelles for World No Tobaco Day, World Heart Day and World Diabetes Day (including event organization, press release, declaration, programs with the mass media, etc).

2003

Bovet P. Panelist. 'Forum: Diabetes'. 50-min program on Seychelles Broadcasting Television. 13 Nov 2003.

Bovet P. Development, together with an Indian Software company (UnitedPro Software Solutions, Chennai, India) of a software for user friendly and powerful electronic management of survey data entry (Esurvey 1.0), for PC and pocket computers.

2002

Bovet P. Development of guidelines for the diagnosis and clinical management of conditions related to CVD (8-25 pages each): 1) Guidelines on the diagnosis and management of hypertension, 2) Guidelines on the diagnosis and management of diabetes and 3) Guidelines on the diagnosis and management of dyslipidemia (integrated in Hand book for Medical Practice for Primary Health Care, Ministry of Health, Seychelles). The 3 guidelines were approved by the Technical Committee of the Ministry of Health in Oct 2002.

Bovet P. Co-organizer of 1st National Conference on Tobacco Control, Victoria, Seychelles, 27 May 2002.

Gervasoni JP, Bovet P. Organizers of Workshop on CVD, Dar es Salaam, Tanzania, 4-6 Apr 2002.

Bovet P. Gervasoni JP. Organizer. Two-day Workshop on Hypertension for Health Care Providers. Dar es Salaam, 24-25 Apr 2002.

Paccaud F, Bovet P. Translation of document WHO STEPwise approach for surveillance of risk factors for CVD from English to French for NMH-WHO, Mar 2002.

Bovet P, Viswanathan B. Investigators of the Global Youth Tobacco Survey (GYTS) in the Seychelles, Ministry of Health, Seychelles, in collaboration with CDC and WHO, Oct 2002.

Bovet P. Development, together with an Indian Software company (UnitedPro Software Solutions, Chennai, India) of a survey software (to enable the conduct the collect of survey information directly to a computer).

Bovet P. Development, together with an Indian Software company (UnitedPro Software Solutions, Chennai, India) of a software for the management of risk factors collection in an ongoing longitudinal study of risk factors in children of Seychelles (to enable the analysis of data collected over time at student level, as identified by unique identification numbers).

2001

Bovet P. UPCCD. 5 min video aired worldwide produced by the World Heart Federation for the World Heart Day on 30 Sep 2001, featuring successful stories in CVD prevention sent to all TV stations worldwide, has included an item from the Seychelles CVD Prevention Program.

Bovet P, Randriamiharisoa A, Gervasoni JP, Development of the web site for the Group of Transition and CVD (GCT) of the IUMSP. The site displays the current activities of the GCT, content of a training course by GCT, publications by the GCT and important links in areas of interest (http://www.iumsp.ch/Unites/gct/msp_info.htm).

Gervasoni JP. Organizer. Scientific seminar on CVD. Dar es Salaam, Tanzania, 6 Dec 2001

Bovet P, Gervasoni JP. Two-Week Workshop on Prevention and Control of Cardiovascular Diseases with Limited Resources, Ministry of Health, Kulhudhuffushi, Maldives, 30 Sep-14 Oct 2001.

2000

Gervasoni JP, Bovet P, Matthies F. Organization and facilitation of "2-Week Workshop on Cardiovascular Disease Prevention with Limited Resources”. Support from University of Lausanne and the Swiss Agency for Development and Cooperation. Bagamoyo, Tanzania, 9-21 Apr 2000

1999

Organization in Seychelles of a 1-week workshop on "Quality of care”. Facilitators: Dr Guillain and Dr Burnier (Uni Lausanne). Grant by the Swiss Agency for International Development and Cooperation (SDC), Bern, Switzerland. Ministry of Health, Seychelles, 8-12 Mar 1999.

1998

Organization in Seychelles of a 1-week workshop on "Hypertension management and control”. Ministry of Health. Facilitators: Prof. B. Waeber and Prof. M. Burnier (Univ. Lausanne). Grant by SDC, Bern, 7-11 Sep 1998.

Organization in Seychelles of a 1-week workshop on "Coherent preventive strategies”, Ministry of Health. Facilitators: Dr B. Somaini (Univ Zurich) Dr F. Kuechler (Univ Balse). Grant by SDC, Bern, Switzerland, 27-31 July 1998.

Ross A. Coordinator of the project "Hypertension in a country in an early stage of epidemiological transition: KAP, screening and utilization of health services”, Dar-es-Salaam, Tanzania, jointly organized by the IUMSP and the Swiss tropical Institute. Grant No 32-51189.97 by the Swiss National Science Foundation, 1998-1999.

1997

Financing by IUMSP of travel expenses and accommodation for several participants to the 4th International Conference on Preventive Cardiology, Montréal, Canada, 29 Jun-3 Jul 1997.

IUMSP, World Health Organization and World Bank. Organization of the Symposium "Elaboration and implementation of community CVD programs in developing countries”, 30 Jun 1997, at the 4th International Conference on Preventive Cardiology, Montréal, Canada, 29 Jun-3 Jul 1997.

IUMSP, US Institute of Medicine and World Bank. Organization of a Meeting on Research, Development, and Institutional Strengthening for Control of Cardiovascular Disease in Developing Countries, Montréal, Canada, 30 Jun 1997.

IUMSP. Organization of a two-week attachment of a Seychellois nurse (G. Madeleine) at the Cardiology Division of the University Hospital of Lausanne, for technical training for the operation of stress electrocardiography, 30 Jun-11 Jul 1997.

Bovet P. Publication of an electronic version of the Seychelles Medical & Dental Journal publishing articles in full on the Internet (www.seychelles.net/smdj) to promote the dissemination of local research (including CVD) from within and towards developing countries, Nov 1997.

1996

Bovet P. Local organizer of the World Heart Federation 29th Ten-Day Teaching Seminar in Cardiovascular Disease Epidemiology and Prevention, Mahé, Seychelles. 30 Jun-12 Jul 1996

1994

Bovet P. Main investigator of the Seychelles Heart Study II. Joint organization with Ministry of Health of Seychelles: IUMSP, University Medical Policlinic, Division of Cardiology and Division of Hypertension of University Hospital of Lausanne, Canton Hospital of St Gallen, Switzerland, May-Dec 1994.

Perret F (Division of Cardiology of University Hospital of Lausanne). First co-investigator of the Seychelles Heart Study II, Jun-Dec 1994.

1993

Yersin C, Bovet P, Gervasoni JP. Hospital-based register of all fatal and non-fatal admissions for CVD, Seychelles, 1993-1999.

1992

Gervasoni JP. Organization of an International Symposium on Cardiovascular Diseases Prevention Strategies. Mahé, Seychelles, 11-13 Aug 1992.

1991

Gervasoni JP. Main investigator of a survey of health knowledge and behaviors on heart health in adolescents. Joint organization by Ministry of Health of Seychelles, Swiss Jura Cooperation, Swiss Agency for International Development and IUMSP. Jul-Oct 1991.

Organization of a 2-week attachment of a Seychellois nurse (J. Quilindo) at the University Institute of Social and Preventive Medicine, Lausanne, Switzerland, for training in data management. Jun 1991.

1990

Bovet P. Organization of an International Symposium on Cardiovascular Diseases. Mahé, Seychelles, 21-23 Mar 1990. Proceedings published in Soz Praeventivmed 1991;36(Suppl. 1):S1-S89. 1990.

1989

Bovet P. Main investigator of the Seychelles Heart Study I. Joint organization by Ministry of Health of Seychelles, Swiss Jura Cooperation, Swiss Agency for International Development and Cooperation, IUMSP, University Medical Policlinic of Lausanne, University Hospital of Lausanne, and Canton Hospital of St Gallen, Switzerland.

11. Grants and awards

Bovet P and co-investigators. Phase 4 study of smoking cessation using nicotine replacement therapy in Seychelles. Funding for medications from World Health Organization (~$12000), 2003-2005.

Gervasoni JP, Leuthold A. Grant for the 10 days visit of Dr Mkamba M in Switzerland. Commission for Research Partnerships with Developing Countries (KFPE), Dec 2003.

Paccaud F. Bill and Melinda Gates Foundation. Commission on Macroeconomics and Health (World Health Organization) more specifically on the prioritization of Health interventions for the poor (2000-2002).

Gevasoni JP. Collaborator in the Stroke Incidence Study for the Hai district and Dar es Salaam Tanzania. Walker R, Mugusi F, Swai M, Unwin N, Alberti G. Welcome Trust grant 2002-2005.

Paccaud F. Disease Control Priorities Project, cco-author for chapter « Cardiovascular Disease » in 2nd edition « Disease Control Priorities in Developing Countries » 1 Aug 2002-31 Dec 2003.

Bovet P, Viswanathan B, and others. Global Youth Tobacco Survey (GYTS) in the Seychelles -2002, WHO-CDC.

Hoffman A, Gervasoni JP, Stoll B. Participation in tropEd, Programme for a Master in international health. Federal Office of Education and Science, Jul 2000-Oct 2001.

Paccaud F. Bill and Melinda Gates Foundation: Funding (writing and review of evidence) of report "Health services for the poor", part of the general report on Macroeconomics and Health (World Health Organization), 2000

Stettler N, Stallings VA, Kumanyiaka C, Bovet P. "Prevalence and risk factors for obesity and overweight status in children in Seychelles, a country in rapid transition”. Grant from the McCabe Fund Pilot Project, Children Hospital of Pennsylvania, 2000-2001.

Burnier M, Bovet P, Mooser V, Schild L, Wong T. "Genetic and molecular basis of hypertension and salt-sensitivity in an African Black population: focus on the epithelial sodium channel”. Grant from the University of Lausanne TANDEM No. 31-51115.97, 1999-2001.

Burnier M, Mooser V, Schild L, Bovet P. "Genetic and molecular basis of hypertension, salt-sensitivity and associated traits in a Black population”. Grant request RATP (Réseaux d’unités de recherche à Axes Thématiques Prioritaires) to the Faculty of Medicine of Lausanne, Switzerland, 1999.

Unit for Prevention and Control for Cardiovascular Disease (UPCCD), Ministry of Health of Seychelles (head P. Bovet) is nominated for World No Tobacco Day Medal, 1999.

Bovet P. Research on epidemiological transition. Grant Prosper No 32-38792.93 from the Swiss National Science Foundation, Bern, Switzerland, 1997-1998.

Paccaud F, Gervasoni JP, Bovet P. Organization of 3 1-week courses for capacity building in Seychelles. Grant by the Swiss Agency for International Development and Cooperation (SDC), Bern, Switzerland, 1998-1999.

Bovet P, Gervasoni JP, Langeler C, Paccaud F. Hypertension in countries in an early stage of epidemiological transition (knowledge, attitudes and practices toward hypertension, consequences on screening and utilization of health services. Grant No 32-51189.97 from the Swiss National Science Foundation, 1998-2001.

Gervasoni JP, Bovet P, Paccaud F. Development of an advanced module of teaching for the Masters of International Health of TropEDEurop: "How to start an efficient and sustainable program of prevention of CVD/NCD with limited resources”. Grant by the Swiss Agency for International Development, Bern, Switzerland, 1999-2000.

Bovet P. Research on epidemiological transition. Grant Prosper No 32-38792.93 by the Swiss National Science Foundation, 1994-1996.

IUMSP is designated a World Health Organization Collaborating Center for Population-Based Research and Prevention in Populations in Health Transition, 1997.

Bovet P, Burnand B, Paccaud F. Programme de recherche et de développement en épidémiologie de transition: l’exemple des Seychelles. Grant No 4006 by the Services des Hospices Cantonaux, Lausanne, Switzerland, 1993-1995.

12. Memberships to professional organizations and boards by main GCT staff

Paccaud F. Member of the Steering Committee of the CVD Research Initiative by the Global Forum for Health Research; TropEDEurop Governor Board; Foundation for Research on Ageing, Geneva; Scientific Board of the Swiss Society for Public Health, Bern; Scientific Board for the Swiss Foundation for Health Promotion, Lausanne; Working Group on Prevention of the Swiss Federation of Physicians, Bern; Committee of the Novartis Foundation for Medical and Biological Sciences Advancement; Scientific Board of the "Réseau d’Epidémiologie Clinique International Francophone” (RECIF); Member of the scientific board at the Division Biology and Medicine of the Swiss National Science Foundation; President of the Foundation of Social and Preventive Medicine, Lausanne;

Vaud Canton Society of Medicine; Swiss Society for Public Health; Swiss Society of Alcohology; Swiss Medical Federation (FMH); Swiss Society of Psychiatric Epidemiology; Swiss Society of Gerontology; Swiss Society of Health Policy; American Public Health Association (APHA) ); World Heart Federation (WHF); Association for Medical Information; Réseau d'épidémiologie clinique internationale francophone (RECIF); International Genetic Epidemiology Society; Society for Epidemiologic Research; International Society of Technology Assessment; International AIDS Society; European Healthcare Management Association; International Society for Quality Assurance in Health Care.

Bovet P. Département Interdisciplinaire d'Etudes Cœur et Vaissaux (DIECV) - Certificat d'Etudes Complémentaires en Recherche Cardiovasculaire (CECRC); National Committee for Tobacco Control, Seychelles (chair); Task Force for Integrated Disease Surveillance and Response, Ministry of Health, Seychelles; Elected member of the Scientific Council on Epidemiology and Prevention of the World Heart Federation (since Feb 1999). Executive Committee of the Diabetic Association of Seychelles. Executive Committee of the Heart and Stroke Association of Seychelles.

Swiss Medical Federation (FMH); Society of Internal Medicine (board of spec. int. med. FMH); Swiss Society for Public Health (board of spec. prevention and public health FMH); International Atherosclerosis Society (IAS); American Heart Association (AHA) Council on Epidemiology and Prevention; European Federation of Internal Medicine (EFIM); Seychelles Medical and Dental Association (SMDA).

Gervasoni JP. Swiss Medical Federation (FMH); Swiss Society for Public Health, European Evaluation Society; Swiss Evaluation Society; World Heart Federation (WHF); Council on Epidemiology and Prevention of the American Heart Association (AHA) Council on Epidemiology and Prevention; Association des Epidémiologistes de Langue Française (ADELF); Member of the TropEDEurop Steering Committee.

13. Participation to boards of medical journals

Paccaud F. Associate editor of Sozial- und Praeventivmedizin, Zurich; Editorial Board of British Medical Journal, London, Journal of Health Services Research and Policy, London, Schweizerische Medizinische Wochenschrift, Journal of Epidemiology and Biostatistics, Journal d’Economie Médicale & Médecine & Hygiène, Geneva.

Bovet P. Editor of Seychelles Medical and Dental Journal (also an Internet edition on www.seychelles.net/smdj); International editorial board of Cardio-Update (New Delhi); Advisory board of African Journal of Drug and Alcohol Studies, Editorial board of Epidemiological Bulletin of Ministry of Seychelles (www.moh.gov.sc/noticeboard.htm).

Appendix 1. CVD research and prevention program in the Seychelles

CVD research and prevention program in the Seychelles islands (Indian Ocean)

A CVD research and prevention program has been initiated since 1989 as a joint project between IUMSP and the Ministry of Health of the Republic of Seychelles. The program aims at 1) describing and analyzing the cardiovascular disease situation in a country experiencing rapid health transition and 2) developing corresponding prevention and control strategies. Population-based surveys in 1989 and 1994 showed high levels of several main risk factors, particularly hypertension as well as some CVD outcomes (peripheral atherosclerosis as measured by high performance ultrasonography). A Unit for Prevention and Control of Cardiovascular Disease (UPCCD) was set up in 1992 in the Ministry of Health of Seychelles and several public health measures have been developed and implemented. This includes media campaigns to rise public awareness, the development of various public health policy instruments, the integration of health education on non-communicable diseases within the regular curriculum in schools, hypertension and diabetes screening programs, ‘heart health clubs’ to improve risk factors control in high risk individuals attending health centers, surveillance systems such as a health-center based national register of hypertension and diabetes among adults and a screening program of hypertension and overweight in all primary and secondary schools. Ongoing studies include a cohort study of risk factors, surveillance of risk factors integrated in school programs, relationship of risk factors in children with birth data and a study of genetic determinants of hypertension. A study of the prevalence of smoking habits and associated factors was conducted in 2002 (Global Youth Tobacco Survey) in collaboration with CDC and WHO. Further policy development in 2002 included the formulation of a national program for tobacco control and ad hoc legislation through a National Committee of Tobacco Control and the formulation of guidelines for the diagnosis and clinical management of hypertension, diabetes and dyslipidemias.

This research and prevention program is described in some detail in several published articles, for example in CVD Prevention 1999;2:261-272;108-112; Cardio Update (New Delhi) 1996;July:10-22; Soz Praventivmed 1995;40:35-43; Wrld Hlth Statist Q 1993; 46(No. 2); 108-112; and Soz Praeventivmed 1991; 36(Suppl. 1): S30-3, Insight Health (May 2001). More specific issues and results have been reported in ~20 other publications (abstracts and full texts are available on the web site of the GCT, address appearing on the cover page of this report).

The UPCCD in the Ministry of Health of the Republic of Seychelles is staffed with 5 local health workers and complemented with consultants from IUMSP (one on a long term basis attachment, PB). Projects have benefited from funding and resources from the Swiss National Science Foundation, various divisions and departments of the Faculty of Medicine of the University of Lausanne (Switzerland), the Service des Hospices Cantonaux (Vaud), the Swiss Canton of Jura, and the Swiss Agency for Development and Cooperation.

Key personnel of the Unit for Prevention and Control of Cardiovascular Disease, Ministry of Health, Seychelles: Pascal Bovet (consultant), George Madeleine, Bharathi Viswanathan, Nadia Ciseau, Murielle Bochud (coordinator of the TANDEM Hypertension Study), Catherine Falconnet (TANDEM Hypertension Study) and Norma Both (TANDEM Hypertension Study).

Appendix 2. Hypertension in a population in an early stage of epidemiological transition

It aims at examining the epidemiology of hypertension and other risk factors; knowledge, attitudes and practices on hypertension, and utilization of health services for hypertension in Dar es Salaam, Tanzania. This research program has been initiated in collaboration with the Tanzanian Health Authorities since 1998 and with the support of the Swiss National Foundation for Science.The study takes place Dar es Salaam, Tanzania. The study examines the prevalence hypertension and its determinants, the strategies for efficient diagnosis of hypertension, the patterns of utilization of health services by hypertensive patients and the effect of health education as a mean of blood pressure control in hypertensive patients. These data will help inform strategies to prevent, detect, and treat hypertension in low-resource settings.

Investigators include Pascal Bovet (1), Jean-Pierre Gervasoni (1), Christian Lengeler (2), Fred Paccaud (1). Study coordinators in Dar es Salaam include Mashombo Mkamba (3),Anne Rwebogora (3), Mariana Balambama (3). The project also includes several other clinical officers.

(1) Institute for Social and Preventive Medicine, Lausanne, Switzerlan; (2) Swiss Tropical Institute, Basel, Switzerland; (3) Ministry of Health, Dar es Salaam, Tanzania.

This research program has been initiated with the Tanzanian Health Authorities since 1998 and with the support of the Swiss National Foundation for Science. As cardiovascular disease is rapidly emerging in developing countries, this research project investigates epidemiological and public health characteristics of hypertension in an urban population in early epidemiologic transition (Dar es Salaam, Tanzania). Research includes prevalence and determinants of hypertension, strategies for efficient diagnosis of hypertension, and utilization of health services by hypertensive patients. After main components of the study were organized and piloted in 1998, 17 local clinical officers collected in 1999 data on blood pressure and related factors in nearly 10,000 adults of five branches of the capital Dar es Salaam. Preliminary results show higher than expected prevalence of hypertension and selected risk factors for hypertension have been identified. Preliminary results provide clues for optimal strategies for efficient hypertension diagnosis (e.g. based on 3 readings at each of two visits). A follow-up part of the research (which was prepared and piloted in the last quarter of 1999) will investigate in 2000-2001 how the newly hypertensive persons (as identified in the survey in 1999) have utilized health services during the one-year interval following hypertension diagnosis. When analysis is finalized, these data will help inform strategies to prevent, detect, and treat hypertension in low-resource settings.

Appendix 3. Two-week workshop ‘Starting a CVD prevention program with limited resources’

The workshop aims at teaching and practicing the main elements needed to initiate a sustainable program of prevention and control of cardiovascular diseases (CVD) and some other related non-communicable diseases (NCD) in regions with limited resources. It combines teaching sessions on the recent scientific knowledge and an extensive practice of analysis and program development tools. In general, the course is organized in the requesting region/country from where participants come from.

The objectives of the workshop are to: 1)·To raise awareness of the participants on the emerging epidemic of NCD/CVD in low and middle income countries; 2) ·To enable the participants to identify and analyze the current CVD situation in their respective countries; 3) ·To equip the participants with the knowledge and skills to initiate a prevention and control program of CVD; 4) ·To build a network of health professionals in low and middle income countries in the field of prevention and control of CVD.

Location.The workshop generally takes place in the region/country where the participants come from. This avoids traveling expenses to the participants and it helps ensuring that the content of the course (epidemiologic assessment, development of a prevention program) is adapted to local needs. The workshop is held in a secluded place (e.g. a hotel away from a main center) that offers accommodation facilities for the sojourn of all participants during the entire workshop’s period. The workshop can be given on request of organizations/individuals from low or middle income countries and date and location (in the host country) are then chosen accordingly.

Lectures aim at delivering the minimal information needed to develop a program in terms of relevance, advocacy, goal setting, and actual organization. All lectures are completed with ‘check lists’ and handouts as resources for the participants. A quick individual assessment is performed at the end of the workshop as an indication of knowledge integration.

Practice aims at training participants with tools needed at the various steps of program development: epidemiologic relevance, situation analysis, advocacy, identification of resources, design, implementation, and evaluation. Participants will conduct, within small groups, a rapid epidemiologic assessment in the field of CVD/NCD (during the first week) and draft the elements of a hypothetical comprehensive CVD prevention and control program (during the second week) adapted to the situation of the participants’ country/region. The main principle of the training sessions is ‘learning by doing’. Along this training, participants will use computers and word-processor, spreadsheet, and statistical software. No previous computer literacy is requested and computers will be made available (at least one computer per group). Participants will present their work (epidemiologic assessment, program draft) in plenary for critical appraisal and learning.

Participants are health professionals from countries with limited resources, preferably with some experience in public health and/or health research (at least two years of working experience). Fluency in English is requested for course in English. Alternatively the course can be given in French (in which case fluency in French is requested). The number of participants is limited to approximately 15-20.

Facilitators include Dr. Pascal Bovet, MPH and Dr. Jean-Pierre Gervasoni, MPH from the Group of Cardiovascular Disease and Epidemiological Transition (GCT) of the IUMSP, Lausanne. The IUMSP is a collaborating center of the World Health Organization since 1994 for population-based cardiovascular research and prevention in populations in health transition. The faculty of the workshop includes generally also one or two other facilitators either from IUMSP or from other Universities.

The workshop has been organized in Bagamoyo, Tanzania, 9-21 Apr 2000 (participants from Ministry of Health, Tanzania) and in Kulhudhuffushi, Maldives, 30 Sep-14 Oct 2000 (participants from Ministry of Health of Maldives).